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ABSTRACT
How Subjective and Objective Memory, Family History, and Knowledge 
of Alzheimer’s Disease Influence Older Adults’
Fear of Developing Alzheimer’s Disease
by
Samantha Lyn French
Dr. Karen Kemtes, Examination Committee Chair 
Assistant Professor of Psychology 
University of Nevada, Las Vegas
It is projected that by the year 2050, the number of Americans with Alzheimer’s 
disease (AD) will rise to approximately 13.2 million. And, because AD is on the rise, 
apprehension about developing the degenerative disease (anticipatory dementia or fear of 
developing AD) has become a topic of study in the past few years. However, most 
studies focusing on anticipatory dementia have used a sample of individuals younger than 
age 65 and have used a single item questionnaire to explore their apprehension. The 
current study utilized 50 adults ages 65 and older to examine anticipatory dementia and 
its relationship with subjective and objective memory, family history, and knowledge of 
AD. Fear of developing AD was assessed using a new 30-item, psychometrically sound 
instrument titled the Fear o f Alzheimer’s Disease Scale (FADS). Results o f the study 
revealed that: (1) in-line with existing research, subjective memory complaints was 
positively associated with fear o f developing AD, (2) family history, knowledge of AD, 
and objective memory were not significantly correlated with fear o f developing AD, (3) 
subjective memory was the only significant predictor of fear of developing AD; neither
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family history, knowledge of AD, nor objective memory predicted fear of developing the 
disease, (4) knowledge of AD was not associated with anxiety, (5) there was no 
significant relationship between subjective and objective memory, and (6) the 
relationship between subjective memory and fear of developing AD was still significant 
after controlling for participants’ negative mood.
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CHAPTER 1
INTRODUCTION
“It’s not me currently with Alzheimer’s disease. But any time I misuse a 
word, forget a name I have and should have known, momentarily lose the 
car in a parking lot, I scare the bergeebers out of me! I fear becoming a 
victim o f Alzheimer’s disease,..” (as cited in Cutler & Hodgson, 2001).
The Bureau of the Census (2005) reports that there are approximately 35.9 million 
people 65 years and older currently living in the United States. It is projected that in 
twenty-five years the number of elderly will reach 72 million. Additionally, there are 4.5 
million Americans with Alzheimer’s disease. This number is expected to dramatically 
increase to 13.2 million by the year 2050 (Hebert, Scherr, Bienias, Bennett, & Evans, 
2003).
Alzheimer’s disease (AD) is a degenerative disease affecting predominantly 
individuals over the age of 60 and in rare cases, individuals as young as 30 (Small et al.,
1997). The onset of AD is gradual, but the progression is continuous. Early symptoms 
of AD are often overlooked, being attributed to normal aging. “Senility,” and/or normal 
aging are not as severe or as progressive as AD, however. Symptoms of AD include 
memory impairment, which is typically one of the earliest symptoms, aphasia, apraxia, 
agnosia, and executive functioning impairment (APA, 2000).
Currently there is no test that can diagnose AD; diagnosis can only be confirmed 
postmortem through autopsy. However, when Alzheimer’s disease is suspected, several 
tests can be conducted to increase the likelihood of an accurate diagnosis. These tests
may include, but are not limited to, computed tomography (CT), magnetic resonance 
imaging (MRI), blood tests, lumbar puncture, neuropsychological evaluation, office- 
based clinical assessment, and an informant interview (APA, 2000; Small et ah, 1997). If 
a diagnosis of AD is made, there are several pharmacotherapy options that can help slow 
the progression of the disease. Presently there is no cure for AD. It is, however, 
extremely important to detect AD early and accurately so that medication can be taken 
while symptoms are still mild, costs associated with AD can be reduced, and families can 
prepare for the challenges that may lay ahead (Small et al., 1997).
Alzheimer’s disease is becoming an increasing health concern due to the recent rise in 
the number o f dementia cases. And, the fact that genetics can play a large role in the 
development o f AD and other dementias, especially in individuals having family 
members diagnosed with early-onset AD (Heston, 1991; Swearer, O ’Donnell, Parker, 
Kane, & Drachman, 2001), there may be cause for more concern among those with a 
family history of the disease. For these and many other reasons, apprehension about 
developing the degenerative disease has become a topic of studies in the past few years. 
There have been relatively few studies, however, looking at the relationship between tear 
of developing AD and other variables, namely subjective memory, objective memory, 
family history of Alzheimer’s and other dementias, and knowledge of Alzheimer’s 
disease.
For some people, experiencing a memory problem may evoke thoughts of developing 
AD or another type of dementia. Thoughts for this group of people are usually only 
fleeting. They generally do not take the idea very seriously nor do they allow it to cause 
much distress. However, for other people, experiencing episodes of forgetfulness can
lead to significant distress and worry about developing AD (Ponds, Commissaris, & 
Jolies, 1997). In 1996, Cutler and Hodgson described a phenomenon termed 
“anticipatory dementia,” that explains these latter individuals. Anticipatory dementia is 
the basic fear that normal memory problems associated with aging are an indication of 
dementia. One study revealed that approximately 92% of individuals with a parental 
history of AD experienced anticipatory dementia (Cutler & Hodgson, 2001).
Anticipatory dementia is a relatively new concept and there is much to learn about it. 
For this reason, we have generated several hypotheses related to fear of developing AD 
that are based upon results and limitations of prior studies.
1. Subjective memory complaints, family history of AD, and knowledge of AD will 
be positively correlated with fear of developing AD. Objective memory will not 
be correlated with fear of developing AD.
2. Subjective memory complaints, family history, and knowledge of AD will 
significantly predict fear o f developing AD. Subjective memory complaints will 
emerge as the best predictor of fear o f developing AD followed by family history 
and knowledge o f AD. Family history of AD and knowledge of AD will emerge 
as predictors which offer unique contributions to predicting fear of developing 
AD above and beyond subjective memory. Objective memory will not 
significantly predict fear o f developing AD.
3. Knowledge of AD will be positively correlated with levels of anxiety.
4. There will be no significant relationship between subjective memory complaints 
and objective memory.
5. The relationship between subjective memory complaints and fear of developing 
AD will be significant even after controlling for negative mood.
CHAPTER 2
LITERATURE REVIEW 
Fear of Developing Alzheimer’s Disease 
The onset of symptoms consistent with certain diseases is disconcerting for many 
individuals. While some studies have addressed concern about developing specific 
diseases with genetic underpinnings like Huntington’s disease (Hunt & Walker, 1991) 
and hypertrophic cardiomyopathy (Siebert, 1995), relatively few studies have looked at 
the fear associated with developing AD.
The first study evaluating older adults’ fear of developing AD was performed in 1986 
(Price, Price, Shanahan, & Desmond, 1986). Researchers found that 84% of participants 
described their perceptions of developing AD using words such as “concerned” (24%), 
“frightened” (22%), “scared stiff’ (20%), and “worried” (19%). Researchers noted that 
at least one participant made the following comment: “I would rather have cancer than 
Alzheimer’s” (Price et al., 1986, p. 420).
Researchers in the Netherlands also found that individuals were afraid of developing 
AD. While conducting informational meetings about the differences between normal 
forgetfulness and dementia, Commissaris and colleagues found that 46% of individuals 
reported attending the informational meetings because they were worried about tbeir 
memory and incipient dementia (Commissaris, Verhey, Jr., Ponds, Jolies, & Kok, 1994).
Although the previous studies were influential in introducing the new research area of 
fear of developing AD, it wasn’t until Cutler and Hodgson’s studies were published that 
research on the topic became recognized. In 1996, Cutler and Hodgson coined the term, 
“anticipatory dementia,” to refer to the concern individuals have about age-associated 
memory impairments being indicative of AD. Since 1996, Hodgson and Cutler have 
published five articles that look at the relationship between anticipatory dementia and 
other variables (Cutler & Hodgson, 1996; Cutler & Hodgson, 2001; Hodgson & Cutler, 
1997; Hodgson & Cutler, 2003; Hodgson, Cutler, & Livingston, 1999).
Cutler and Hodgson (1996) hypothesized that memory problems, once associated 
with normal aging, now cause fear, and are being seen as early symptoms of AD or other 
dementias. Their hypothesis was accurate. Using a single question (i.e., “I ’d like to ask 
how concerned you are about personally developing Alzheimer’s disease. Would you 
say you are very concerned, somewhat concerned, not very concerned, or not at all 
concerned about developing Alzheimer’s?” ), to measure anticipatory dementia, they 
found that 10% of participants were “very concerned,” 44% were “somewhat concerned,” 
32% were “not very concerned,” and 14% were “not at all concerned."
After determining that anticipatory dementia was, in fact, a valid fear for adults, 
Hodgson and Cutler (1997) explored the construct further by examining its relationship 
with well-being, as measured by life satisfaction, depression, psychiatric 
symptomatology, and self-reported health status. Researchers found that, for participants 
with a family history of AD, life satisfaction was significantly related to anticipatory 
dementia. In the control group (i.e., no family history of AD), a significant relationship 
was found between anticipatory dementia and both psychiatric symptomatology and self­
reported health. Hodgson and Cutler (1997) concluded that individuals experiencing 
anticipatory dementia may perceive their lives more negatively than those who do not 
fear developing AD.
To further explore fear of developing AD, Hodgson et al. (1999) examined 
anticipatory dementia in both individuals with a family history of AD and those without a 
family history. Using their single-item question, they found that individuals with a 
family history of AD exhibited high levels of symptom-seeking behavior in addition to 
reporting anxiety about developing the disease: 67% reported being “very” or 
“somewhat” concerned while only 40% of controls reported being “very” or “somewhat” 
concerned. Additionally, controls were unlikely to report symptom-seeking behavior. 
Based upon the results, the researchers suggested that individuals having parents with AD 
search for AD symptoms as a result of experiencing anticipatory dementia.
In 2001, Cutler and Hodgson, conducted a follow-up study to their 1996 study and 
found similar results. Ninety-two percent of participants who had a parent with AD 
reported being either “very” or “somewhat” concerned about developing AD. In the 
matched control group, only 47% of the participants expressed the same concern.
In their last study, to date, Hodgson and Cutler (2003) examined symptom-seeking 
behavior in both individuals with a family history of AD and in those without a family 
history. Results were similar to those found in their 1999 study: a significant relationship 
existed between symptom-seeking behavior and anticipatory dementia.
The research conducted by Cutler, Hodgson, and colleagues (Cutler & Hodgson,
1996; Cutler & Hodgson, 2001; Hodgson & Cutler, 1997; Hodgson & Cutler, 2003; 
Hodgson et al., 1999) expanded the modest literature on anticipatory dementia. Although
influential, the research was not flawless. All o f their research utilized individuals 
between the ages of 40 and 60. Although this is an important age group to assess, these 
individuals are not in the typical age range for the development o f AD. One would 
conjecture that tear o f AD would increase as the age of onset approaches. Therefore, 
assessing individuals after the typical age of onset (i.e., 65 years and older), may reveal 
distinct tear.
Cutler, Hodgson, and colleagues’ other major flaw resided in their methodology. In 
assessing anticipatory dementia, all of their studies utilized a single-item question: “I ’d 
like to ask you how concerned you are about personally developing Alzheimer’s disease. 
Would you say you are very concerned, somewhat concerned, not very concerned, or not 
at all concerned about developing Alzheimer’s?” A single-item questionnaire threatens 
reliability and validity. A multiple-item questionnaire would not only reduce these 
threats, but would both better describe and better predict individuals’ fear o f developing 
AD.
During the time that Cutler, Hodgson, and colleagues were conducting various 
studies, other researchers began investigating the new field of anticipatory dementia as 
well. Reese, Cherry, and Norris (1999) addressed “memory fears” in older-adults. To 
measure “memory fears,” eight questions were asked pertaining to “apprehensions that 
one has about the ways that memory loss can affect one’s well-being and quality of life” 
(Reese et al., 1999, p. 233). The most frequent apprehension reported was the fear of 
losing one’s independence. Participants also reported fear that they would inaccurately 
represent their memories. The third most frequent response was fear of developing 
dementia.
Roberts and Connell (2000) conducted a study that looked at attitudes, beliefs, and 
experiences regarding AD. Their research revealed that 74.3% of participants thought 
they would develop AD within their lifetime. Over half of the participants (52.2%) 
expressed concern over developing AD. And, 34.5% reported being more concerned 
about developing AD than another health problem.
To add to the anticipatory dementia literature, Werner (2002) conducted a study that 
looked at individuals without a family history of AD and their concerns about developing 
the disease. Twelve percent of participants reported no concern while 46% reported 
being very concerned about developing AD.
Laforce and McLean (2005) studied fear and knowledge o f AD among young and 
older adults. Their sample consisted of 127 young adults ages IBABO years and 119 older 
adults ages 55 to 90 years. To measure fear and knowledge o f AD, a 40-item 
questionnaire designed specifically for the study was administered to participants. O f the 
40 questions, only one question was devoted to measuring fear of AD: “How afraid are 
you o f developing Alzheimer’s Disease?” Participants rated their fear on a 5-point Likert 
scale ranging from “not at all” to “very afraid.” Younger participants’ fear of developing 
AD was significantly higher than that of the older adults.
To address the paucity of questions used to measure tear of AD, French (2005) 
created a scale, titled the Fear of Alzheimer’s Disease Scale (FADS), to assess older 
adults’ tear of developing AD. The FADS is a 30-item self-report measure used to assess 
anticipatoiy dementia across three different dimensions: older adults’ basic and 
metamemory based tear of developing AD (General Fear), physical symptoms that older 
adults experience due to tear o f developing AD (Physical Symptoms), and older adults’
catastrophic thinking associated with fear of developing AD (Catastrophic Attitude). 
Participants indicate their level of agreement with the statement using a 5-item Likert- 
type scale ranging from “never,” to “always.”
Researchers administered the FADS to 101 older adults ages 65-91. Results of the 
study illustrated that the FADS is a reliable and valid instrument in the evaluation of fear 
of developing AD among older adults. It is the first scale with good psychometric 
properties available to directly address fear of developing AD (French, 2005).
In addition to determining the psychometric properties of the FADS, French (2005) 
also found that both family history and subjective memory were significant predictors of 
fear of developing AD while objective memory was not a significant predictor. The 
research confirmed prior findings; older adults are afraid of developing AD. However, 
by using a 30-item questionnaire researchers were able to determine what specifically 
older adults were afraid of (e.g., losing their independence, not recognizing family 
members) rather than simply determining that the fear, in fact, exists.
In summary, previous research has found that individuals are afraid o f developing 
Alzheimer’s disease. Only one study to date, however, has assessed this fear among 
older adults utilizing a multiple-item questionnaire (French, 2005). In this study, the 
researchers demonstrated that a multiple-item questionnaire may both better describe and 
better predict individuals’ fear of developing AD compared with a single-item question 
about such fear. The current study hopes to address older adults’ fear of developing AD 
and the relationship between this fear and subjective memory, family history of AD, 
knowledge of AD, and objective memory.
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Relationship between Fear o f  Developing AD and Subjective Memory Complaints
Subjective memory, or metamemory as it is also commonly known, has been 
researched extensively, especially in the elderly population. It is “the knowledge one 
possesses about the functioning, development, use, and capacities of the human memory 
system in general, and one’s own memory in particular” (as cited in Dixon & Hultsch, 
1983, p. 689).
Subjective memory complaints are common among the elderly, and refer to the 
awareness an individual has about his/her own memory decline. Many researchers have 
examined subjective memory complaints in an attempt to determine if complaints 
indicate the beginning of Alzheimer’s disease or other forms of dementia. To examine 
subjective memory complaints, a variety o f questionnaires have been used. Some 
researchers use a single-item question, while others employ lengthy measures. Whereas 
many studies have looked at the relationship between subjective memory complaints and 
objective memory, only five studies to date have looked at the relationship between 
subjective memory complaints and fear of developing AD.
Cutler and Hodgson (1996) looked at the relationship between anticipatory dementia 
and subjective memory. To measure subjective memory, they used the Short Inventory 
of Memory Experiences (SIME; Herrmann, 1984), which consists of 24 items pertaining 
to experiences with memory. Additionally, they used six questions developed 
specifically for the study to measure subjective memory: four were closed-ended items 
and the other two were open-ended questions. The composite score from the six 
questions resulted in the Memory Assessment Index (MAI; Cutler & Hodson, 1996). The 
researchers found that subjective memory and anticipatory dementia were related.
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Specifically, negative assessments of one’s memory were related to greater concern about 
developing AD. Contrary to one of their hypotheses. Cutler and Hodgson did not find a 
difference between participants with family history and participants without family 
history with regard to the relationship between subjective memory and fear of developing 
AD. They did, however, discover that participants having a parent with AD were more 
fearful about developing AD than participants having no family members with either AD 
or another dementia.
Similar to their 1996 study, Cutler and Hodgson (2001) used the SIME and several 
ratings o f memory functioning to assess subjective memory. They found that subjective 
memory complaints played a large role in fearing the development of AD in both 
participants with a family history of AD and in participants without a family history of 
AD. Furthermore, participants whose parents developed AD expressed far more concern 
over developing the disease than individuals without a family history o f AD.
In addition to researching symptom-seeking behavior, Hodgson and Cutler (2003) 
looked at the relationship between subjective memory and anticipatory dementia. To 
measure subjective memory, they used the SIME and several questions pertaining to 
memory functioning. The researchers found that subjective memory and anticipatory 
dementia were significantly related.
Werner (2002) also examined the relationship between subjective memory and fear of 
developing AD. To assess subjective memory, she asked three questions about whether 
the individual had problems remembering things, names of relatives, and/or times and 
places. The questions were rated on a 4-point Likert-type scale ranging from “not at all” 
to “very frequently”. A composite score was determined from the three questions.
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Results revealed that the most significant predictor o f anticipatory dementia was 
worrying about their memory problems. This finding was consistent with Cutler and 
Hodgson’s studies (1996 & 2001).
To add to the scant literature, French (2005) looked at the relationship between tear 
of developing AD and subjective memory. Researchers utilized the 30-item Fear of 
Alzheimer’s Disease Scale (FADS; French, 2005) to assess older adults’ tear o f 
developing AD, and the 64-item Memory Functioning Questionnaire (MFQ; Gilewski & 
Zelinski, 1986) to examine subjective memory. Like Werner (2002), they found that 
subjective memory was a significant predictor of fear of developing AD.
All studies, to date, have found a significant relationship between subjective memory 
and tear of developing AD. Two o f these studies used a more powerful statistical 
analysis (i.e., multiple regression) to show that, not only does a significant relationship 
exist between subjective memory and fear of developing AD, but that subjective memory 
significantly predicts this fear; individuals who believe their memory is poor are more 
likely to tear developing AD than individuals who believe their memory is normal or 
above average. Based upon results from the literature, the current study is hypothesizing 
that subjective memory complaints will significantly predict tear o f developing AD.
The current study is using an elderly population to look at fear of developing AD.
The majority of studies examining anticipatory dementia looked at middle-age 
individuals. And, while they found significant results, it seems logical that, because the 
likelihood of developing AD dramatically increases after the age o f 65 (Fairer, 
O ’Sullivan, Guppies, Growdon, & Myers, 1989), elderly individuals would be even more
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fearful of developing AD than middle-aged individuals based purely upon the probability 
of them developing the disease.
Relationship between Fear o f  Developing AD and Family History o f AD
“Whenever I asked about the cause [of AD], I tried to look nonchalant, 
because by this point, every time I lost my keys or forgot someone’s first 
name, I thought that the disease was in the blood” (as cited in Hodgson et 
ak,1999X
AD was thought to have a genetic component as early as 1929 (as cited in Farrer, 
1997). Since then, hundreds of studies have attempted to identify which genes play a role 
in the development of AD. More specifically, researchers have attempted to identify 
specific genes associated with both early-onset AD (diagnosis occurring before age 65) 
and late-onset AD (diagnosis occurring after age 65).
Individuals with early-onset AD account for a relatively small number of AD cases.
It is an autosomal dominant transmitted disease that has been associated with four genes 
to date. Specifically, it has been linked with mutation at codons 670, 671, and 717 of the 
beta-amyloid precursor protein (APP) gene located on chromosome 21 (Goate, et al., 
1991; Murrel, Farlow, Ghetti, & Benson, 1991), and the SMT2 gene located on 
chromosome 1 (Levy-Lahad, et al., 1995). More commonly, individuals with early-onset 
AD show a mutation on the AD3 gene located on chromosome 14 (Goate, et al., 1991; 
Schellenberg, et al., 1992; Sherrington, et al., 1995; St George-Hyslop, et al. 1992), or on 
the Apolipoprotein E (ApoE) gene, which is the most researched gene linked with both 
early- and late-onset AD. Because the current sample is comprised of individuals aged 
65 and older, consequently falling into the late-onset AD category, research pertaining to 
the ApoE gene and its association with late-onset AD will be discussed in greater detail 
than the genes associated with early-onset AD.
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ApoE is a plasma protein with 3 common alleles (allele-2, allele-3, and allele-4) 
encoded on chromosome 19. These 3 alleles correspond to 6-phenotypes (2/2, 3/3, 4/4, 
2/3, 2/4, 3/4). Initially, it was thought that ApoE-4 occurred disproportionately more in 
individuals diagnosed with late-onset AD than in controls (Saunders, Strittmatter, 
Schmechel, 1993; Strittmatter et al., 1993). More recent studies, however, have revealed 
that ApoE-4 is more common in not only late-onset AD, but in early-onset AD as well 
(van Duijn et al., 1994).
Most molecular and epidemiological genetic studies determine the risk of developing 
AD by calculating an odds ratio (OR). To calculate an OR, researchers determine the 
population with AD (d), and the number of cases without AD (n), yielding an odds ratio 
ofd/n  (Jorm, 1990).
In 1997, Farrer et al. conducted a meta-analysis that looked at the relationship 
between the ApoE genotype and AD. Farrer and his colleagues compiled data from 40 
out of 48 possible research groups, representing a total of 5930 patients with probable or 
definite AD and 8607 controls without dementia. Researchers found the ORs for 
Caucasian participants from clinic and autopsy based studies to be as follows; (1) 
participants with genotype 2/4 revealed an OR equal to 2.6 (95% confidence interval =
1.6-4.0), (2) for participants with 3/4, the OR equaled 3.2 (95% Cl = 2.8-3.8), and (3) for 
4/4, the OR was 14.9 (95% Cl = 10.8-20.6). For participants with genotypes 2/2 and 2/3, 
ORs were decreased (OR=0.6, 95% Cl == 0.2-2.0 and OR-0.6, 95% Cl = 0.5-0.8 
respectively). The results suggest that there is a significant relationship between ApoE-4 
and AD. Other research supports this finding as well (Corder et al., 1993; Hall et al., 
1998; Massaia et al., 2001):
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Epidemiological studies are another approach when looking at family history of AD. 
In 1989, St. George-Hyslop and his colleagues did a review of the literature on 
epidemiological studies. The researchers investigated family history o f AD using three 
approaches: (1) family studies in which pedigrees were analyzed (2) twin studies, and (3) 
survey studies where a variety of methods and test populations from various studies were 
compiled.
At the time of the review, 88 families reporting familial AD had been discussed in the 
literature. Out of the 88 pedigrees, family members developing AD equaled 48.6%. In 
order for a trait to be considered solely an autosomal dominant trait, the proportion of 
individuals affected with a particular disease must equal 50%. Results from the literature 
suggest that, although the percentage of AD cases did not equal the 50% level, it did 
approximate the percentage expected. St. George-Hyslop et al. (1989) discussed 
limitations of the family studies investigated in their review. Namely, only 26 of the 88 
families tested were able to provide sufficient evidence for AD being an autosomal 
dominant trait. The other 62 did not have enough family members affected in multiple 
generations to support the notion of AD being an autosomal dominant trait.
Nevertheless, while determining whether or not AD is an autosomal dominant trait is 
important, the fact remains that almost 50% of individuals with a family history of AD 
developed the disease at some point in their lifetime indicating a strong genetic 
component.
A review of twin studies revealed that 32 monozygotic (MZ) twin pairs and 7 
dizygotic (DZ) twin pairs, with at least one individual in the pair being afflicted with AD, 
had been studied at the time of the review. Concordance rates were 44% for the MZ pairs
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and 40% of the DZ pairs. Additionally, age of onset differed in MZ concordant twin 
pairs. These results are worth comparing to Huntington disease (HD), a purely autosomal 
dominant trait. In twin studies of HD, concordance rates for MZ pairs equals 100%. 
Additionally, the age of onset in HD twin pairs is very similar. Results from the AD twin 
studies suggest that AD is not a fully autosomal dominant trait; it may be caused by other 
genetic and environmental factors. Results from the AD twin studies should be 
interpreted with caution since the number of twin pairs studied was extremely small.
Survey studies are more accurate in looking at family history o f AD because o f their 
ability to determine both the likelihood of developing AD among relatives of AD patients 
and the ratio of AD revealing familial aggregation (St. George-Hyslop et al., 1989). In 
their review of survey studies, St. George-Hyslop and his colleagues found that, in earlier 
studies, increased risk to parents (10-14.4%) and siblings (3.8-13.9%) of AD patients was 
significant, yet somewhat unconvincing. More recent studies, using Kaplan-Meier life 
table methods, show more substantial results: (I) the likelihood of developing AD among 
first degree relatives of controls was 10%, (2) the likelihood increased to 50% when the 
individual has a first degree relative with AD. Results suggest an autosomal dominant 
trait. O f the six survey studies reviewed, only one found conflicting results (Fairer, O ’ 
Sullivan, Guppies, Growdon, & Myers, 1989).
Additional epidemiological studies have found that family history greatly contributes 
to an individual’s increased risk of developing AD. In case-controlled studies, the risk of 
developing AD ranged from 39% to 64.3% in those with a family history of the disease 
(Farrer et al., 1990; Lautenschlager et al., 1996; Massaia et al., 2001; Van Duijin, Farrer, 
Guppies, & Hofman, 1993). Researchers using ORs found that the risk ranged from 2.62
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to 13.0 (Broe & Henderson, 1990; Canadian Study of Health and Aging, 1994; Li et al., 
1992; Prince, Cullen, & Mann, 1994; Salih, 2000).
Only one study found contradicting results. Launer et al. (1999) performed a meta­
analysis of four European population-based studies. They found a nonsignifieant 
increased risk of 1.6 for developing AD in individuals with two or more first degree 
relatives with the disease.
When looking speeifically at tear of developing AD and family history, studies have 
shown that tear of developing AD tends to be greater when there is a family history of the 
disease (Cutler & Hodgson, 1996; Cutler & Hodgson, 2001). This fear ean be further 
heightened when the individual’s family member developed early-onset AD or when 
he/she has two parents with AD (Birkett, 1989).
Freneh (2005) explored the relationship between family history o f AD and fear of 
developing AD among older adults. Rather than using a eorrelational design, however, 
the study again used a more powerful statistieal analysis (i.e., multiple regression) to 
show that family history of AD significantly predicted fear of developing AD. Results 
signified that individuals with a family history are more afraid o f developing the disease 
than individuals without a family history. Again, Freneh’s study allowed researchers to 
not only explore the relationship between family history of AD and fear of AD, but the 
many facets o f the tear as well.
Based upon genetie studies and other studies that have addressed the relationship 
between family history of and fear o f AD, the current study is hypothesizing that family 
history o f AD will be a signifieant predictor of anticipatory dementia.
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Relationship between Knowledge o f  AD and both Fear o f  Developing AD and Anxiety
“A lot o f knowledge can be a bad thing.. .sometimes people get scared of 
knowing too much.”
- Man with Cystic Fibrosis 
(Chapman & Bilton, 2004, p. 369)
As evidenced by the above quote, sometimes knowledge can be scary. However, 
very few studies have investigated the relationship between fear o f developing AD and 
knowledge o f AD. Commissaris and colleagues (1994) were one o f the first to address 
this relationship. Researchers eondueted informational meetings to edueate individuals 
on the differences between normal forgetfulness and dementia. Four hundred-fifty 
attended the meetings. O f the 450, 246 participants completed both pre-test and post-test 
questionnaires. The average age of participants was 58 years. To assess knowledge of 
AD, partieipants were asked 5 questions as both baseline and follow-up. Additionally, 
participants answered “yes” or “no” regarding whether or not they were afraid of 
dementia. Sixty-six percent of individuals that were afraid of their memory and ineipient 
dementia were reassured after attending the meetings. However, contrary to researchers’ 
hypothesis, there was no correlation found between increased knowledge and anxiety 
about developing dementia.
Commissaris and eolleagues (1995) eondueted another study looking at the effeet of 
knowledge on eoneern about dementia. In their previous study, they eondueted 
informational meetings about the differences between normal forgetfulness and dementia. 
The current study utilized an informational brochure to educate individuals on this 
difference. Approximately 475 men and women participated in the study (M age = 66 
years). At baseline, 25% of individuals reported being “very mueh eoneemed” about 
dementia, 52% reported “little coneem” and 23% reported “hardly any/no concern.”
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After reading the brochures, 77% of individuals reporting “much concern” said their 
concern decreased substantially. Researehers eoncluded that informational brochures on 
the differences between normal forgetfulness and dementia can help reduce individuals’ 
fear about developing dementia.
Commissaris and colleagues’ (1995) study provides useful information about the 
relationship between knowledge of AD and fear of developing dementia. However, they 
did not utilize a questionnaire to assess knowledge. They assumed that after reading the 
informational broehure about the differences between normal forgetfulness and dementia, 
individuals would be more knowledgeable about dementia. It is necessary to have both 
pre and post-tests to confirm this assumption. Additionally, both studies performed by 
Commissaris and colleagues (1994 & 1995) addressed fear o f dementia utilizing a single 
question. As French (2005) demonstrated, a multiple-item questionnaire provides a 
better measurement o f individuals’ fear o f developing AD.
LaForce and McLean (2005) utilized a 40 item questionnaire specifically designed to 
assess fear of developing AD and knowledge of AD. Participants answered questions 
about general knowledge, risk faetors, cognition, and personality with regard to AD. As 
with previous research, only one question expressly addressed participants’ fear of 
developing AD. Results of the study revealed that younger individuals (M age -  19.6,
SD = 3A) knew more about AD than older individuals (M age = 67.9, SD = 7.9). 
Covariance analysis indicated that the differences between the groups could not be 
accounted for by edueation. Additionally, the younger adults were more fearful of 
developing AD than older adults. Researchers concluded that the more knowledge 
individuals have about AD, the more fearful o f the disease they are.
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Although LaForce and McLean (2005) added to the pre-existing literature, the 
relationship between fear of developing AD and knowledge of AD needs to be further 
addressed. Specifically, much like other researchers, LaForce and McLean questioned 
participants about their tear using a single question. As explained previously, using a 
single item to address this construct possess a threat to validity and reliability. 
Additionally, it does not address the various aspects of fear of developing AD. The 
relationship between fear of AD and knowledge of AD should be examined using 
psyehometrieally sound instruments that incorporate multiple questions.
The previous studies specifically address how knowledge affects individuals’ concern 
about AD or dementia. Other researchers, however, have addressed the relationship 
between knowledge of dementia using a more generic construct, anxiety. And, even 
though these studies do not assess fear of developing AD directly, previous research has 
shown that anxiety and fear of developing AD are significantly correlated (French, 2005).
Graham, Ballard, and Sham (1997a) examined the relationship between knowledge of 
dementia and anxiety among 109 caregivers of dementia patients ages 65 and older.
Each participant was interviewed and administered the following assessment schedules 
relevant to the current study: (1) the Geriatric Mental State Schedule (Copeland,
Kelleher, & Kellet, 1976) to assess psychiatric health; and (2) and the Dementia 
Knowledge Questionnaire (Graham, Ballard, & Sham, 1997b) to assess caregivers’ level 
of knowledge of dementia. Researchers found that caregivers possessing greater 
knowledge of dementia had significantly higher rates of anxiety.
Proctor, Martin, and Hewison (2002) also looked at the relationship between 
knowledge about dementia and anxiety among caregivers. Fifty caregivers ages 65 and
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older agreed to participate in the study. Caregivers’ knowledge about dementia was 
assessed using the Dementia Quiz (Gilleard & Groom, 1994) and their levels of anxiety 
were measured using the Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith, 1983). The findings substantiated the research performed by Graham, Ballard, 
and Sham (1997a). Proctor and colleagues (2002) found that there was a significant 
relationship between increased knowledge and anxiety. Specifically, caregivers’ 
biomedical knowledge was predictive of anxiety.
Medical Student Disease
The relationship between health knowledge and anxiety is not a new topic to 
psychology. Medical Students’ Disease (MSD), also known as Medical Students’ 
Syndrome (MSS), nosophobia, and medicalstudentitis, is a construct that can be found in 
the literature as early as 1945 (Wyler, 1945).
Woods and colleagues (1966) defined MSD as “the development o f either symptoms 
or hypochondriacal anxiety about the disease being studied by the student” (p. 785). Two 
studies concluded that approximately 70% to 80% of medical students have a “positive 
history” of the disease at some point during their education (Hunter, Lohrenz, 
Schwartzam, 1964; Woods, Natterson, & Silverman, 1966). Sixty-two percent of 
individuals believed that the cause of their MSD was knowledge about the disease in 
question.
Since 1945, many studies have examined MSD. Most studies revealed that, while 
studying a particular illness, medical students focus on their bodily symptoms and falsely 
believe that they have the latest “deadly” disease being studied (Candel & Merckelbach, 
2003; Howes & Salkovskis, 1998; Hunter, Lohrenz, Schwartzam, 1964; Moss-Morris &
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Petrie, 2001; Woods, Natterson, & Silverman, 1966). Kellner, Wigging, & Pathak (1986) 
found that, although medical students had an increased rate o f health related anxiety, it 
was no different than that of controls. Additionally, Singh and colleagues (2004) found 
that medical students did not have higher levels of health anxiety. In fact, medical 
students in years 1 and 4 had significantly lower health-related anxiety than controls. 
Nonetheless, the majority of research has substantiated the notion o f MSD.
Using the MSD concept, researchers have performed studies showing that MSD 
affects non-medical individuals possessing increased levels o f knowledge as well. 
Ferguson (1996) based his study on the notion of MSD to hypothesize that the level of 
medical knowledge would be positively associated with the level o f hypochondriacal 
concern. He assessed 40 female and 18 male undergraduate students (M age = 21.8 
years, SD = 3.6). Ferguson found that the more individuals knew about disease etiology, 
the more concerned they were about developing that disease.
The concept of MSD was further broadened when Hardy and Calhoun (1997) 
examined students’ perception of having a psychological disorder after learning about the 
various mental illnesses in an Abnormal Psychology course. Researchers questioned 119 
students enrolled in Abnormal Psychology (M age = 20.56, SD  = 4.29) about their 
concern over past and present psychological disorders in both themselves and family 
members. Hardy and Calhoun (1997) found that concern about both their own and their 
family members’ psychological health was fairly low. However, individuals either 
majoring or planning to major in psychology reported significantly more concern about 
psychological dysfunction than non-psychology majors. Additionally, individuals were
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more worried that someone in their family could be diagnosed with a personality 
disorder.
Although the concept of MSD has not been applied to the relationship between 
knowledge of AD and fear of developing the disease, it is not difficult to see that it could 
be relevant; the more individuals know about Alzheimer’s disease, the more afraid they 
become of developing it. Based upon the concept of MSD and the previous literature 
examining the relationships between knowledge of AD and both fear of developing AD 
and anxiety, the current study is hypothesizing that knowledge of AD will significantly 
predict both fear of developing AD and anxiety.
Relationship between Fear o f  Developing AD and Objective Memory
AD is heterogeneous in its symptomatology and course. Each individual experiences 
AD somewhat differently. While one person may experience aphasia, for example, 
another individual may not. Regardless of the variants, however, everyone afflicted with 
AD experiences memory problems. Whether using diagnostic criteria from the 
International Classification of Diseases, 10''’ revision, (ICD-10; World Health 
Organization, 1992), the Diagnostic and Statistical Manual of Mental Disorders, d"’ 
edition, (DSM-IV-TR; APA, 2000) or the Neurological and Communicative Disorders 
and Stroke -  Alheimer’s Disease and Related Disorders Association (NINCDS-ADRDA; 
McKhann, et al., 1984), one criteria remains constant; in order to be diagnosed with AD, 
an individual must experience impairment in their memory.
Hundreds of studies have looked at objective memory in individuals diagnosed with 
AD. The ways in which researchers measure objective memory vary greatly. In general, 
researchers use neuropsychological tests that assess short and long term memory.
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executive functioning, attention, temporal and spatial orientation, abstract reasoning, 
constructional abilities, language deficits, and activities o f daily living (Bouchard & 
Rossor, 1999; Mohr, Dastoor, & Claus, 1999).
Scores on objective memory assessments fluctuate depending upon the stage of AD 
that the patient is in. Neuropsychological evaluations reveal that, in the early stages of 
dementia, many AD patients will experience difficulty with orientation, memory, 
judgment, and word-finding. In the intermediate stages, the impairments present in the 
early stages are amplified. Additionally, individuals with AD will begin having difficulty 
with activities of daily living. In the late stages, individuals are completely reliant upon 
help from others; all autonomy is lost (Mohr et al., 1999).
An interesting observation has been made by many clinicians about distinguishing 
pseudodementia from dementia. In pseudodementia, an individual generally presents in 
the clinician’s office with subjective memory complaints. Typically the results of 
objective tests, however, reveal no memory impairments. Individuals with true dementia 
usually present in the clinician’s office with family members. The patient frequently does 
not acknowledge experiencing any problems with memory. In fact, he/she may minimize 
or ratiopalize the memory impairments. Yet, family members recognize that a problem 
exists. In the case o f true dementia, objective assessments o f memory reveal an actual 
problem with memory as opposed to pseudodementia cases where subjective memory 
complaints are more prevalent than actual memory impairments (Bouchard & Rossor, 
1999).
Because memory impairment is an essential criterion in the diagnosis o f AD, one 
might conclude that objective memory would be highly related to fear of developing AD.
25
However, the researcher is hypothesizing that objective memory will not significantly 
predict fear of developing AD. One reason for this hypothesis is that individuals 
experiencing memory difficulties usually do not believe they have a problem with their 
memory. Family members initiate the testing. Therefore, it would seem that they would 
not be worried about developing it as much as if  they had subjective memory eomplaints. 
The hypothesis is also based on research pertaining to the relationship between subjective 
and objective memory. Research has shown there to be a signifieant relationship between 
subjective memory and fear of developing AD. And, most studies found no relationship 
existing between objective and subjective memory (see section titled “Relationship 
between Objective and Subjective Memory in the Elderly”). Therefore, it seems logical 
to deduce that, because subjective memory is hypothesized to significantly predict fear of 
AD, objective memory would be hypothesized to not predict fear o f developing AD. 
Although this relationship was directly assessed in only study, it was substantiated 
(French, 2005).
French (2005) also looked at the relationship between objective memory and fear of 
developing AD among older adults. To assess objective memory, the following tests 
were administered; (1) Logieal Memory I & II from the Weehsler Memory Scale (WMS- 
III), (2) Digit Symbol-Coding from the Weehsler Adult Intelligence Scale (WAIS-III),
(3) Digit Span from the WAIS-III, and (4) the Abbreviated Boston Naming Test. A 
composite score was created from these tests. The scores from each test were weighted 
so that one test score did not influence the composite score more than any other score. 
Results from the study revealed that, although subjective memory and family history
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significantly predicted fear of developing AD, objective memory did not. The current 
study is hoping to replicate these findings.
Relationship between Objective and Subjective Memory in the Elderly 
Between the years 1967 and 2006, over 70 studies looking at the relationship between 
objective memory and subjective memory have been published. It is a topic that has 
caused much controversy due to its inconsistent findings. Researchers are still attempting 
to determine whether or not individuals complaining of memory problems actually 
exhibit impaired memory performanee.
Positive Relationship
Several studies have found a significant relationship between memory complaints and 
performance on memory tests in older adults (Dixon & Hultseh, 1983; Gagnon et al., 
1994; Johansson, Allen-Burge, & Zarit, 1997; Jonker, Launer, Hooijer, & Lindeboom, 
1996; Jonker, Lindeboom, & Hooijer, 1995; Riege, 1982; Wang et al., 2000; Zelinski, 
Gilewski, & Thompson, 1980). This relationship was also found to be significant in 
relatives of patients with early-onset AD (LaRue et al., 1996; McPherson, La Rue, Fitz, 
Matsuyama, & Jarvik, 1995). Additionally, while Wang et al. (2000) found that 
subjeetive memory did not prediet dementia, Johansson, Allen-Burge, & Zarit (1997) did 
find that eomplaints about memory performanee over a 2-year period were predictive of 
cognitive decline.
Weak/Modest Relationship 
Several studies have found a positive, yet weak/modest relationship between 
subjeetive and objective memory despite some efforts to reduee previous methodologieal
27
problems (Hanninen et al., 1994; Hertzog, Park, Morrell, & Martin, 2000; Jorm et al., 
1994; MeDonald-Miszezak, Hertzog, & Hultseh, 1995; Sehmidt, Berg, & Deelman,
2001; Zelinski, Bumight, & Lane, 2001). Additionally, Hanninen et al. (1994) looked at 
the relationship between depression and subjective memory. They found that the two 
variables were not related. On the eonverse, Hertzog et al. (2000) found that depression 
was signifieantly related to subjeetive memory.
Christensen (1991) and Bassett & Folstein (1993) found that the relationship between 
subjeetive and objeetive memory varied by group. Christensen’s (1991) results revealed 
that memory performanee was worse in elderly subjeets who believed their memory 
impairment to be worse than other individuals of their same age. Bassett and Folstein 
(1993) diseovered that individuals expressing memory eomplaints were more likely than 
individuals not eomplaining of their memory to have impaired memory performanee.
Other researehers have found that, although there is a weak or modest relationship 
between memory eomplaints and memory performanee, subjective memory is more 
assoeiated with depression than with objeetive memory (Bolla, Lindgren, Bonaeeorsy, 
Bleeker, 1991; O ’Hara, Hinriehs, Kohout, Wallaee, & Lemke, 1986).
No Relationship
An overwhelming number of studies have found no relationship existing between 
memory eomplaints and memory performanee. One of the first o f these studies was 
eondueted by Kahn, Zarit, Hilbert, & Niederehe (1975). Kahn and his eolleagues used 
both psyehiatrie patients and relatives for eollateral information as partieipants. They 
found that although there was no relationship between subjeetive and objeetive memory, 
there was a strong positive relationship between subjective memory and depression.
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Other studies using non-demented individuals also found that there was no 
relationship between objective and subjective memory (Best, Hamlett, & Davis, 1992; 
Derouesne et ah, 1989; Flicker, Ferris, & Reisberg, 1993; French, 2005; McGlone et al., 
1990; O ’Connor, Pollitt, Roth, Brook, & Reiss, 1990; Rabitt & Abson, 1991; Riedel- 
Heller, Matschinger, Sehork, & Angermeyer, 1999; Schofield et al., 1997; Sunderland, 
Watts, Baddeley, & Flarris, 1986; Taylor, Miller, & Tinklenberg, 1992; Williams, Little, 
Scales, & Blockman, 1987; Zarit, Cole, & Guider, 1981; Zelinski, Gilewski, & Schaie, 
1993). Several o f these same studies found depression to be highly related to subjective 
memory (Derouesne et al., 1989; McGlone et al., 1990; O ’Connor et al., 1990; Rabitt & 
Abson, 1991; Sehofield et al., 1997; William et al., 1987). Conversely, Zarit et al. (1982) 
found that mood had only a minimal relationship with subjeetive memory.
The results from studies looking at the relationship between memory appraisals and 
memory performance are mixed. Few studies have found a positive significant 
relationship. The majority of studies on this topie have found either no relationship or a 
weak/modest relationship.
It seems that the disparity in the data ean be attributed to the fact that subjective 
memory is based upon some psychological aspect whereas objective memory is a pure 
measurement o f memory without the intrusion of individuals’ personality/psychological 
traits. While objeetive measures remain fairly stable aeross studies, measurement of 
subjeetive memory varies greatly. Some subjeetive memory questionnaires use a variety 
of questions, including those that address the psychological/personality eomponent of 
memory eomplaints. Others use a single question. The way in which subjective memory 
is measured could greatly affect the relationship between objective and subjective
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memory. Regardless of the reasons for the disparity in the literature, the inconsistencies 
still exist. Based upon the majority of the results, the researchers hypothesize that there 
will not be a signifieant relationship between subjeetive and objeetive memory.
Additionally, beeause many studies have shown there to be a significant relationship 
between subjective memory and depression, it is possible that negative mood could 
significantly impact the relationship between subjective memory and fear o f developing 
AD. Only one study has addressed the effeets of negative mood on this relationship. 
Freneh, 2005) found that the relationship between subjective memory performanee and 
fear of AD remained significant even after controlling for the effeets o f negative mood. 
Based on these results and on the literature showing that subjective memory is 
significantly correlated with fear o f developing AD, it is hypothesized that the 
relationship between subjeetive memory and fear of AD will remain significant even after 
the effeets of negative mood have been removed.
30
CHAPTER 3
METHODS
Participants
The sample consisted of fifty, community dwelling, non-institutionalized, older adults 
(24 males and 26 females) ages 65-84 (M = 72.24; SD = 5.37). O f the 50 participants, 5 
were single, 26 were married, 11 were divorced, and 8 were widowed. The sample was 
predominately Caucasian (92%) with African American (2%), Asian (4%), and Native 
American (2%) individuals comprising the remainder. With regard to edueation, 4% 
reported “some high sehool or less,” 14% “graduated high sehool or reeeived their GED,” 
4% earned either a “technieal or associates degree,” 26% reported attending “some 
college,” 20% received their “Bachelor’s degree,” 2% attended “some graduate sehool,” 
14% earned their “Master’s degree,” and 16% reported earning a “Doctoral degree (Ph.D. 
or other doetoral)” or another “professional degree (e.g., M. D., J. D.).” Participants were 
reeruited from the general community by placing advertisements in local newspapers, 
some specifically targeting the elderly, and by word of mouth.
Design and Procedure 
Interested persons contacted the primary researcher at the telephone numbers 
provided. Informed consent was obtained over the telephone from each interested person 
in accordanee with the UNLV OPRS guidelines for the proteetion o f human subjects.
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The researeher spoke direetly to the interested party, verified age, asked questions about 
neurologieal disorders and medieations, and administered the Mental Status Questionaire 
(MSQ; Kahn, Goldfarb, Pollaek, & Peek, 1960) to rule out obvious dementia. A eopy of 
the MSQ is in Appendix II. Persons with an MSQ seore less than eight were told that 
they did not qualify for this study. Additionally, any individual with a known 
neurologieal disorder (i.e., Parkinson’s disease, Huntington’s disease, Alzheimer’s 
disease, Piek’s disease, Creutzfeldt-Jaeobs disease, Vaseular dementia, stroke, 
hydroeephalus, brain damage, delirium) were exeluded, as these ean signifieantly impaet 
memory performanee. Furthermore, any individual taking a medieation for their memory 
(i.e., Arieept, Exelon, Razadyne, Namenda) were exeluded from the study as these 
medieations may eause individuals to perform better on the objeetive memory tests than 
they would without medieation. O f the interested individuals, six were exeluded from the 
study.
Before partieipating in the study, interested individuals were given the MSQ (Kahn et 
ah, I960) via the telephone to rule out obvious dementia. Additionally, other pertinent 
information (i.e., demographies, medieal history, medieations, psyehologieal history, 
family history of AD, questions pertaining to personal experienee with AD) was 
obtained. If an individual met the inelusion eriteria explained above, an assessment was 
seheduled to be eompleted at the UNLV eampus. Before testing eommeneed, the 
researeh proeedures were explained to the partieipants and informed eonsent was 
obtained in aeeordanee with the UNLV OPRS guidelines for the proteetion of human 
subjeets.
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Participants were evaluated by one of three trained graduate students. To ensure that 
the interviewers were highly qualified, each interviewer completed approximately five 
hours o f training on administration of the instruments. Each interviewer observed a 
testing session completed by the primary researcher before he/she conducted his/her own 
testing session. After that, the primary researcher observed the interviewer. After 
observations were completed, the interviewer was able to administer the evaluations 
without the presence of the primary researcher.
Before completing any objective memory assessments, participants completed the 
Memory Functioning Questionnaire (MFQ; Gilewski, Zelinski, & Schaie, 1990) so that 
the participant’s perception of his/her memory was not affeeted by performanee on 
objective memory tests. The tests were administered in the following order;
1. Mental Status Questionnaire via the telephone prior to testing session to 
determine eligibility
2. Background Questionnaire via the telephone prior to testing session to determine 
eligibility
3. Fear o f Alzheimer’s Disease Scale (FADS)
4. Memory Functioning Questionnaire (MFQ)
5. Logical Memory I
6. Digit Symbol -  Coding
7. Digit Span
8. Abbreviated Boston Naming
9. Geriatric Depression Scale (GDS)
10. Logical Memory II
33
11. California Verbal Learning Test -  second edition (CVLT-II)
12. Knowledge about Alzheimer’s Disease (KADS)
13. State-Trait Anxiety Inventory -  Form Y (STAI-Y)
After the interview was completed, scores from the individual objective memory 
assessments were compared to normative data for individuals o f the same age. The 
primary researcher was supervised by a licensed clinical psychologist when participants 
obtained results outside the clinically normal range. The participant received notification 
either in person or via telephone of whether their test results were within a normal range 
or if additional testing was recommended. If the results suggested that a follow-up was 
necessary, the participant was given referrals to local neurologists, neuropsychologists, 
and psychologists. Referral information was available upon request to all participants 
regardless of the outcome of the assessment results. Of the 50 participants tested, three 
individuals received negative feedback and were subsequently provided with referrals.
Measures 
Demographic questionnaire
Participants were given the demographic questionnaire via the telephone prior to the 
testing session to determine eligibility. Questions included information about age, 
gender, marital status, ethnicity, education, medical history, current medications related 
to memory decline, psychological history, and questions pertaining to experience with 
AD. Participants were also asked about family history of AD and/or other dementias. 
When the participant reported a family history of AD or other dementias, he/she was 
asked to reveal whether the family member diagnosed was a first or second degree
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relative or if  he/she has multiple family members diagnosed. The partieipant was also 
asked how emotionally elose he/she is to the family member(s) diagnosed. The 
partieipant responded to this question on a 5-point Likert-type seale ranging from 1 (“Not 
at all Close”) to 5 (“Extremely Close”). A copy of the questionnaire is in Appendix III.
Assessment o f  Fear o f  Developing Alzheimer’s Disease
To examine levels of anticipatory dementia, partieipants were given the Fear of 
Alzheimer’s Disease Scale (FADS; French, 2005). The FADS is a 30-item self-report 
measure used to assess anticipatory dementia aeross three different dimensions: older 
adults’ basic and metamemory based fear o f developing AD (General Fear), physieal 
symptoms that older adults experience due to tear of developing AD (Physical 
Symptoms), and older adults’ eatastrophie thinking assoeiated with tear o f developing 
AD (Catastrophie Attitude). Partieipants indicated their level of agreement with the 
statement using a 5-item Likert-type scale ranging from “never,” to “always.” The 
minimum and maximum scores possible on the FADS are 0 and 120, respectively. A 
copy of the FADS is in Appendix IV.
The FADS is a valid and reliable measure (Freneh, 2005). Internal eonsisteney was 
measured in a sample of lOI  older adults ages 65 and older. Cronbaeh’s alpha for 
“General Fear,” “Physical Symptoms,” and “Catastrophic Attitude” was found to be .94, 
.85, and .80, respectively. Cronbaeh’s alpha for the entire instrument was .94. The 
FADS was also found to have good construct reliability; scores on the FADS were 
signifieantly eorrelated {r = .216, p  < .05) with the total seore on the State-Trait Anxiety 
Inventory -  Form Y (French, 2005).
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Assessment o f  Subjective Memory 
The Memory Functioning Questionnaire (MFQ; Gilewski, Zelinski, & Schaie, 1990) 
was used to assess the participants’ perceptions of their own memory. It is a 64-item 
self-rated scale designed to examine a person’s metamemory, or perceived memory 
functioning, across three different dimensions: general frequeney of forgetting 
(Frequeney of Forgetting), the importanee of what is forgotten (Seriousness of 
Forgetting), and the amount of effort made, through mnemonics, to avoid failures 
(Mnemonic Usage). Items are rated on a 7-point Likert seale ranging from I (frequently 
a problem) to 7 (never a problem). Scores on the MFQ can range from 64 to 448, with a 
lower seore indieating greater pereeived memory diffieulty.
Metamemory is assessed by asking the partieipant to eompare his/her memory now in 
eomparison to how it was 1,5, 10, and 20 years ago and at the age of 18. The lower the 
score an individual receives on this scale, the more the participant perceives his or her 
memory to be a problem. Therefore, higher scores on the MFQ factors are indicative o f a 
low level of memory eomplaints, infrequent use of mnemonies, and the pereeption that 
memory is still intaet. A eopy of the MFQ is in Appendix V.
The MFQ has been tested extensively on an older adult sample. Three-year test-retest 
reliabilities of the subscales ranged between .22 and .64. When looking at internal 
eonsisteney in a sample o f 693 16 to 89 year olds, Cronbach’s alpha was found to be 
between .82 and .93 (Gilewski & Zelinski, 1986).
Assessment o f  Knowledge o f  Alzheimer’s Disease 
The Knowledge about Alzheimer’s Disease Seale (KADS; Carpenter, Balsis, 
Otilingam, Hansen, & Gatz, 2006) was used to assess participants’ knowledge of
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Alzheimer’s Disease. The KADS is a 50-item questionnaire that assesses various aspeets 
of knowledge about AD. Forty-nine of the 50 questions are presented in a true-false 
format. Question 50 asks partieipants to indieate how mueh knowledge they think they 
have about AD on a 10-point Likert scale ranging from “I know nothing at all” to “I am 
very knowledgeable.” A copy of the scale is in Appendix VI. Seores on the KADS 
range from 0 to 49, with a higher score indicating greater knowledge of Alzheimer’s 
disease. The KADS is eurrently in its pilot form. As sueh there are no data available to 
demonstrate the psychometrie properties of the questionnaire.
The KADS is the revised version of the Alzheimer’s Disease Knowledge Test 
(ADKT; Dieekmann, Zarit, Zarit, & Gatz, 1988). Seientifie knowledge about AD has 
inereased dramatically since the development of the ADKT. As such, the ADKT is an 
outdated measure of knowledge o f AD. Nonetheless, the ADKT is a psyehometrieally 
sound measure as evidenced by eoefficient alphas ranging from .71 to .92. Construet 
validity for the ADKT was also established (Dieekmann, Zarit, Zarit, & Gatz, 1988).
Assessment o f  Objective Memory 
Logical Memory I  and II  Subscales o f the Weehsler Memory Scale (WMS-III)
In Logical Memory I (LMI), the examiner reads two different stories (story A & B) 
aloud to the partieipant. Story B is read twiee. After the stories are presented, the 
partieipant is asked to retell eaeh of the stories from memory. If the partieipant 
inaceurately reealls or omits story and thematic units (e.g. units pertaining to main ideas 
presented in the story), he/she receives 0 points. The reeall total seore for Logical 
Memory I ean range between 0 and 75 points. A higher seore indieates better 
performanee. The Psyehologieal Corporation (1997) found that the reliability coeffieient
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for individuals between 65 and 80 averaged .87. Test-retest reliability analysis revealed a 
correlation coefficient of .77
In keeping with the administration guidelines, there was a 25-30 minute delay 
between Logical Memory I and II. In the current study, participants completed Digit- 
Symbol Coding, Digit Span, the Abbreviated Boston Naming, and the Geriatrie 
Depression Seale (GDS) during the delay between Logieal Memory I and II. In Logieal 
Memory II (LMII), the examiner asks the partieipant to retell both stories A and B from 
the immediate condition. After the participant reports everything he/she remembers from 
the two stories, the examiner asks yes/no questions about both stories. On Logical 
Memory II, the partieipant ean reeeive a reeall total score anywhere between 0 and 50 
with a greater seore again indieating better performanee. The Psyehologieal Corporation 
(1997) performed a reliability analysis. The results of their analysis revealed a 
correlation coeffieient of .81 for individuals aged 65 to 89. The correlation coefficient 
for test-retest reliability equaled .74. Both Logical Memory I and II showed good 
eontent, eriterion, and eonstruet validity.
California Verbal Learning Test -  Second Edition (CVLT-II)
The California Verbal Learning Test -  Second Edition (CVLT-II; Delis, Kramer, 
Kaplan, & Ober, 2000) measures memory for verbal information. The CVLT is 
composed of two word lists each comprising 16 words from four categories (Furniture, 
Vegetables, Ways o f Traveling, and Animals). List A is the primary list and List B is the 
interferenee list. The examiner presents List A five separate times. Each word is spoken 
aloud by the administrator at a rate of just over I per seeond. After eaeh list has been 
presented, the partieipant freely recalls the items on List A. After the five immediate free
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recall trials of List A, the examiner presents List B. The participant is asked to recall all 
of the words from list B. This is followed by short delay free and cued recall trials of List 
A, 20-minute long delay free and eued reeall trials of List A, a long delay recognition 
trial of List A, and a forced-choice reeognition task of List A. Scores on the CVLT-II 
ean range between 0 and 80 for total recall, and 0 and 16 for both short and long delay 
recall. The CVLT-II is a valid and reliable measure. Good internal consistency was 
evidenced by a coefficient alpha .82 and a test-retest study yielded r = .82. Its validity is 
based upon its relationship with the original CVLT, which was proven highly reliable and 
valid. The correlation between the CVLT and the CVLT-II ranged from .63 to .86 (as 
cited in Plake, Impara, & Spies, 2003, p. 177).
Digit Symbol -  Coding Subscale o f  the Weehsler Adult Intelligence Scale (WAIS-Ill)
In Digit Symbol-Coding, the participant is asked to copy hieroglyphic-like symbols 
that are paired with numbers. Using the key provided, the partieipant finds the symbol 
that corresponds with the number and draws it in the box below the number. The 
partieipant has 120 seconds to fill in as many boxes as possible. The score is determined 
by the number of symbols correctly drawn. The maximum seore possible is 133.
Additionally, participants completed both the Incidental Learning -  Pairing, and 
Incidental Learning - Free recall subtests o f Digit Symbol -  Coding. In the Incidental 
Learning -  Pairing subtest, the subject is asked to write down the symbol that 
corresponds to eaeh number without looking at the symbol key. The maximum number 
of points is 18. In the Incidental Learning -  Free Reeall subtest, the subject is asked to 
write down all of the symbols that he/she can remember in any order. The participant can 
obtain a maximum of 9 points on this subtest. The Psychological Corporation (1997)
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reports good psychometric properties for the WAIS-III. Specifically, it reports an 
average reliability coefficient for the Digit Symbol -  Coding subscale of .87 in 
individuals between the ages of 65 and 89. Test-retest reliability for individuals between 
55 and 74 was found to be .85 and .91 in individuals between 75 and 89. Digit Symbol- 
Coding was also shown to be valid, as measured by construct, criterion, and content 
validity (Psychological Corporation, 1997).
Digit Span Sub test o f the Weehsler Adult Intelligence Scale (WAIS-III)
There are two sections to the Digit Span subtest: Digit Span forward and Digit Span 
backward. In both Digit Span forward and backward, the examiner reads a string of 
numbers aloud at a rate of one number per second. Each trial is comprised of two sub­
trials consisting of equal numbers in the string. The string of numbers in each trial gets 
progressively longer. The participant continues until he/she inaeeurately repeats both 
sub-trials of the trial. In digit span forward, whieh is administered first, the partieipant 
repeats the string of numbers in the order in which they were read. In digit span 
backward, the participant repeats the string of numbers in the reverse order of what was 
read. The maximum total score possible for both Digit Span forward and backward is 30 
points. The Psyehologieal Corporation (1997) reports an average reliability eoeffieient of 
.89 in individuals between the ages of 65 and 89 for both digits forward and baekward. 
Test-retest reliability analysis shows an average reliability of .85 in individuals between 
the ages of 55 and 75, and .69 in individuals between the ages of 75 and 89. Digit Span 
was also shown to be valid, as measured by construct, criterion, and content validity 
(Psyehologieal Corporation, 1997).
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Abbreviated Boston Naming Test
The Boston Naming Test (BNT) is a naming vocabulary test (Kaplan, Goodglass, 
Weintraub, 1978). The 15-item shortened version of the BNT is from the Consortium to 
Establish a Registry for Alzheimer’s Disease (CERAD) neuropsychological battery 
(Morris, Mobs, Rogers, Fillenbaum, & Heyman, 1988). In the BNT, the examiner 
presents 15 pictures from the original BNT to the participant. The pictures consist of five 
high frequency, five medium frequency, and five low frequency items. The participant 
has 10 seconds to respond. In this version o f the BNT, no semantic or phonetic cues are 
given. The participant’s score is based upon the number of correct responses. The 
maximum possible seore is 15 with higher seores indieating better performanee. One- 
month test-retest reliability was found to be .91 in patients and .77 in eontrols (Welsh- 
Bohmer, & Mobs, 1997). Additionally, longitudinal studies have shown that the 
abbreviated version of the BNT has good validity (Morris, Edland, Clark, & Galasko, 
1993).
Negative Mood
The Geriatrie Depression Seale (GDS; Yesavage et al., 1983) is a 30-item 
questionnaire measuring depression in older adults using a yes/no format. Seores on the 
GDS range from 0 to 30 with a higher score indicating more severe negative mood 
symptoms. A copy o f the GDS is in Appendix VII. The initial validation study indicated 
high internal consistency, with an alpha of .94, and high convergent validity as indicated 
by a eorrelation of .83 with the Hamilton Rating Seale for Depression (Yesavage et al., 
1983). One week test-retest reliability indieated a correlation of 0.85 (Bums, Lawlor, & 
Craig, 1999). Yesavage suggested using a score of 11 or higher as an indication of
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depression. In fact, the sensitivity rate was 96% when using a cut-off score of 10, 
whereas the specificity rate was 96% (Olin, Schneider, Eaton, Zemansky, & Pollock, 
1992). When a cut-off score of 14 was evaluated, the sensitivity rate decreased to 80% 
but the specificity rate increased to 100% (Bums, Lawlor, & Craig, 1999).
Anxiety
The State-Trait Anxiety Inventory -  Form Y (STAI; Spielberger, Gorsuch, Lushene, 
Vagg, & Jacobs, 1983) is designed to measure anxiety in “normal” individuals. There are 
two 20-item sections. One section measures state anxiety (A-state), which is anxiety at a 
specific moment. This can change easily as a result o f changes in the individual’s 
environment. The other section measures trait anxiety (A-trait). Trait anxiety does not 
change readily because it is considered the individual’s stable anxiety proneness. The 
state anxiety scale is scored along a 4-point Likert scale ranging from “not at all” to “very 
much so.” The trait anxiety scale is also scored along a 4-point Likert-type scale, only 
this scale ranges from “almost never” to “almost always.” Scores on the STAI-Y overall 
scale as well as both the state and trait anxiety subscales range from 40 to 160 and 20 to 
80, respectively, with higher scores indicating more severe anxiety symptoms. In a study 
by Spielberger and Krasner (1988) the STAI was found to have high internal consistency 
(.86 to .95). The trait section was found to have good test-retest reliability o f .65 to .86.
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CHAPTER 4
RESULTS 
Description of the Measures 
Before computing descriptive statistics, the data were screened for completeness, 
accuracy in data entry, and outliers. Additionally, skewness and kurtosis were evaluated. 
According to Curran, West, and Finch (1996), acceptable kurtosis and skew values lie 
between ± 2 and ± 7, respectively. All variables evaluated (i.e, Fear of Developing 
Alzheimer’s Disease Scale - FADS, Memory Functioning Questionnaire - MFQ, 
Knowledge about Alzheimer’s Disease Scale - KADS, composite score of objective 
memory, composite score of cognitive measures. Geriatric Depression Scale - GDS, and 
State-Trait Anxiety Inventory -  Form Y - STAI-Y) approximated normality with regard 
to kurtosis and skew. Maximum scores, means, and standard deviations for these 
variables and their subscales are presented in Table 1. The total scores were used for the 
FADS, MFQ, STAI-Y, and GDS unless otherwise specified. Descriptive information 
about each variable will be provided later in this section.
Family history of AD was operationalized as the participants’ total number of first 
and second degree relatives diagnosed with the disease. Participants were asked to report 
having a first-degree relative, a second-degree relative, or both with the disease. Twenty- 
four percent of the participants reported a family history of AD. O f these cases, 12% and 
14% endorsed having a first-degree and second-degree relative diagnosed with the
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disease, respectively. Participants reported, on average, .42 family members diagnosed 
with AD.
Description o f  the FADS 
The average score on the FADS was 25.44 (SD = 20.91) with a maximum score of 
120, which indicates that, on average, participants in the current study endorsed “Rarely” 
as the option for each statement. Specific rates of response for the FADS are presented in 
Table 2. With regard to the three factors of the FADS (General Fear, Physical 
Symptoms, and Catastrophic Attitude), the maximum scores possible were 68, 32, and 
20, respectively. The average score was 18.02 (SD = 14.30) on the General Fear factor, 
indicating “Rare” responses on average, 1.42 (SD = 4.20) on the Physical Symptoms 
factor, indicating “Never” responses on average, and 6.0 (SD = 4.69) on the Catastrophic 
Attitude factor, indicating “Rare” responses on average. Most subjects ranked their fear 
relatively low overall. A much lower percentage of individuals endorsed the higher 
symptomatology categories, suggesting some restriction in range.
Description o f  the MFQ  
On the MFQ, lower scores indicate greater perceived memory problems. Therefore, 
higher scores on the MFQ factors are indicative of a low level o f memory complaints, 
infrequent use of mnemonics, and the perception that memory is still intact. The opposed 
coding of these variables is quite confusing with regard to data analysis and 
interpretation. To facilitate easier data analysis and interpretation, the data was recoded 
such that lower scores indicate a low level o f memory complaints and higher scores 
indicate greater perceived memory problems.
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The average score on the MFQ was 284.14 (SD = 48.62) with a maximum score of 
448, which equates to an average response of “Sometimes” / “Fair” / “Somewhat 
Serious” / “Same” depending upon the dimension being evaluated. This suggests that 
participants neither perceived their memories as very good nor very poor.
Description o f  the KADS 
The maximum number of points possible on the KADS equals 49. The mean number 
of points earned for the current study’s sample was 37.54 (SD = 3.80), which indicates 
that the average percentage of items correctly answered on the KADS was 76.6%. 
Assuming a normal distribution, the fact that participants responded much higher than 
chance (i.e., 50%), it can be concluded that participants were well above average in terms 
of their knowledge of Alzheimer’s disease.
Description o f  Objective Memory Tests 
With regard to the objective memory tests, two composite scores were created: (1) a 
composite score of objective memory measures (i.e.. Logical Memory I, Logical Memory 
II, CVLT-II recall total score, CVLT-II short-delay recall, CVLT-II long-delay recall), 
and (2) a composite score of cognitive measures (i.e.. Logical Memory I, Logical 
Memory II, CVLT-11 recall total score, CVLT-11 short-delay recall, CVLT-II long-delay 
recall. Digit Symbol, Digit Span, Boston Naming Test). The two composite scores were 
created to address both memory specifically, and additional constructs (i.e., attention and 
concentration, processing speed, confrontational naming) that may reflect memory 
difficulties and a subsequent diagnosis o f dementia.
Both composite scores were calculated using averages of z-scores for each measure. 
The first composite score, objective memory, is comprised of measures specifically used
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in evaluating short-term and long-term memory. The second composite score, cognitive 
measures, encompasses cognitive measures often used in diagnosing dementia. These 
measures not only include memory measures, but also measures o f attention, processing 
speed, and confrontational naming. The objective memory composite score is the score 
of vital importance to the hypotheses and subsequent analyses. However, the additional 
measures in conjunction with the true memory measures are necessary for providing 
adequate feedback about memory performance to each participant. To evaluate the 
relationship between the two composite measures, a Pearson product-moment correlation 
was calculated between the objective memory and cognitive measures constructs and was 
found to be significant {r= .951, p <  .001).
When assessing performance on the memory tests (i.e.. Logical Memory and CVLT 
tests), we found that participants scored an average o f 120.92 points (SD = 28.76) out of 
a possible 237, which suggested that participants’ memory in the current study was 
within the average range when compared to individuals o f similar age, ethnicity, and 
education level (note: CVLT norms are based solely on age). When assessing 
performance on cognitive measures (i.e., Logical Memory, CVLT, Digit Symbol, Digit 
Span, and BNT), it was found that participants scored an average of 243.48 points (SD = 
41.62) out of a possible 442, suggesting that, when taking all cognitive measures into 
account, participants again scored in the average range with regard to memory, attention 
and concentration, processing speed, and confrontational naming when compared to 
individuals of similar age, ethnicity, and education level (note: CVLT and BNT norms 
are based solely on age).
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Description o f  the GDS 
Participants can obtain a maximum of 30 point on the Geriatric Depression Scale 
(GDS). Researchers suggest that a score of 0-9 indicates “normal” levels o f negative 
mood, 10-19 indicates “mild” depression, and 20-30 reveals “severe” depression 
(Yesavage et al., 1983). In the current study, participants received an average of 4.6 
points (SD = 4.73), indicating “normal” levels of negative mood in general.
Description o f  the STAI-Y 
On the STAI-Y, participants can receive a maximum of 160 points. Eighty of those 
points can be obtained on both the State and Trait Anxiety subscales. In the current 
study, participants received an average of 29.34 (SD = 10.20) and 31.28 (SD = 8.78) 
points on the state and trait anxiety subscales, respectively. On the STAI-Y, as a whole, 
participants scored an average o f 60.62 points (SD = 17.23). Results indicate that 
participants, on average, were experiencing relatively low levels o f anxiety at the time of 
testing.
Hypothesis Testing
The Relationship between Fear o f  Developing AD and Subjective Memory Complaints, 
Family History o f  AD, Knowledge o f  AD, and Objective Memory 
The correlations among family history, FADS, MFQ, KADS, GDS, STAI, and the 
objective memory and cognitive measures composite scores are presented in Table 3.
A central hypothesis to the current research was that fear of developing AD would be 
correlated with subjective memory, family history, and knowledge of AD, but not to 
objective memory. To test this hypothesis, Pearson product-moment correlations
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between the MFQ, family history, KADS, objective memory composite score, cognitive 
measures composite score, and the FADS were computed. As hypothesized, subjective 
memory was positively associated with the FADS (r = .33, p  < .05). Contrary to the 
hypothesis, however, significant correlations were not observed between family history 
of AD and the FADS (r = .10, p  > .05), nor the KADS and the FADS (r = -.10, p  > .05). 
Furthermore, emotional closeness with an afflicted family member, as experienced by the 
participant, was also not significantly correlated with the FADS (r = .511,/» > .05).
Lastly, as hypothesized, the FADS was not correlated with the objective memory (r = - 
.13, p >  .05) or cognitive measure (r = -.22,/» > .05) composite scores.
Predictors o f  Fear o f  Developing Alzheimer’s Disease
Flierarchical regression was conducted to determine the degree to which subjective 
memory (MFQ), family history of AD (number of family members endorsed by each 
participant), knowledge of AD (KADS), and objective memory (composite score of 
objective memory tests) predicted adults’ fear of developing AD.
Variables were entered into the hierarchical regression analysis in sequential blocks: 
(1) MFQ, (2) family history, (3) KADS, and (4) the objective memory composite score. 
The order in which the variables were entered into the equation was based upon the 
strength of the correlations found previously in French (2005) such that the variable most 
strongly correlated with the FADS (i.e., MFQ) was entered into the equation first. French 
(2005) found that the MFQ was most strongly positively correlated with the FADS (r = 
.32, p  < .001) followed by family history {r = .26, p  < .01). In this study, it was also 
found that objective memory was not significantly correlated with the FADS {r -  -.09, p  
> .05). For this reason and for the reason that objective memory was again expected to
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not predict fear, objective memory was entered into the equation last. Little is known 
about the relationship between knowledge of AD and fear of AD. Thus, the KADS was 
entered into the equation after the MFQ and family history, but before the objective 
memory composite score.
Table 3 displays the correlations between the variables. Table 4 displays the 
unstandardized regression coefficients (B) and standard errors (SE B), the standardized 
regression coefficients (B), adjusted , and Rechange for each step in the regression.
After step 1, with subjective memory in the equation, R^ = A \ ,F { \ ,  48) = 6.03,/» < 
.05. Addition of family history of AD, knowledge of AD, and objective memory did not 
reliably improve R^ at steps 2, 3, or 4 of the regression analysis. After step 4, with all 
independent variables in the equation, R^ = .13, F{4, 45) = 1.12, p  > .05. Results from the 
hierarchical regression analysis revealed that neither family history of AD, knowledge of 
AD, nor objective memory improved prediction of older adults’ fear of developing AD 
beyond that afforded by subjective memory.
The Relationship between Knowledge o f  AD and Levels ofAnxiety 
A Pearson product-moment correlation was computed between the KADS and the 
STAI-Y to examine the hypothesis that a positive association would exist between the 
variables. Results of the analysis revealed no significant relationship (r = -.16,/» > .05). 
The Relationship between Subjective Memory Complaints and Objective Memory 
To test the hypothesis that there would be no significant relationship between 
subjective memory complaints and objective memory, a Pearson product-moment 
correlation was calculated between the MFQ and the objective memory and cognitive 
measures composite scores. Data analysis revealed that, in fact, no significant
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relationship existed between the MFQ and either of the composite scores (objective 
memory; r = 26 , p  > .05; cognitive measures: r = 2 6 ,p  > .05).
The Relationship between Fear o f  Developing Alzheimer's Disease and 
Subjective Memory Complaints after Controlling fo r  Negative Mood 
Significant correlations were found between the FADS and the MFQ {r= .33,p  < 
.05) and the FADS and the GDS (r = .42, p  < .01). No significant correlation was 
observed between the MFQ and the GDS (r=  .16, p >  .05). As proposed, a partial 
correlation was conducted to examine the relationship between the FADS and the MFQ 
after removing the effects of the GDS to ensure that negative mood was not affecting the 
relationship between subjective memory and fear of developing AD. The analysis 
revealed a p r =  .30, p  < .05. Results of this analysis support the hypothesis that the 
relationship between fear of developing AD and subjective memory would still be 
significant even after controlling for the effects of negative mood. This finding implies 
that the relationship between subjective memory and fear o f developing AD is 
sufficiently strong and independent of negative mood.
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CHAPTER 5 
DISCUSSION
Relationships with and Predictors o f Fear of Developing Alzheimer’s Disease 
Fear o f  Developing AD and Subjective Memory Complaints 
In the current study it was hypothesized that subjective memory complaints would be 
positively correlated with and significantly predictive of fear of developing AD. These 
hypotheses were substantiated, confirming prior research findings that a significant 
relationship exists between subjective memory and fear of developing AD (Cutler & 
Hodgson, 1996; Cutler & Hodgson, 2001; French, 2005; Hodgson & Cutler, 2003, 
Werner, 2002). The fact that all published studies to date, including the current study, 
have found a significant relationship between subjective memory and fear of developing 
AD, substantiates the notion that older adults are more likely to fear developing AD if 
they perceive their memory as poor.
Fear o f Developing AD and Family History o f  AD  
Based on the study by French (2005), it was also hypothesized that family history of 
AD would be significantly correlated with and predictive of fear o f developing the 
disease. In contrast to French (2005), the current study found a relationship in the 
predicted direction, albeit non-significant. The results, therefore, failed to confirm the 
proposed hypotheses, signifying that individuals with a family history o f AD are no more 
afraid o f developing the disease than individuals without a family history.
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The reason for the discrepancy between studies is somewhat perplexing considering 
the similarities in methodology. Both studies operationalized family history of AD in the 
same way: an individual was considered to have a family history of AD if either a first or 
second degree family member was diagnosed with AD. Additionally, both studies used 
the FADS to assess older adults’ fear of developing AD. The fact that the variables are 
identical leads the researcher to conjecture that the inconsistency in the results may be 
due to the differences in the samples studied.
Participants in the current study were recruited differently than those in the previous 
study because of more stringent rules implemented by the UNLV Institutional Review 
Board. In French’s (2005) study, individuals were recruited from a wide variety of 
locations including retirement homes, senior centers, adult living complexes, and local 
neurology clinics. Additionally, many of the participants were tested in these facilities 
because of their inability to travel to UNLV for testing. In fact, the majority o f testing 
appointments occurred in the community as opposed to on the UNLV campus. In the 
current study, very few subjects were recruited from senior facilities; the vast majority of 
participants were recruited from the community via newspaper ads and word of mouth. 
Moreover, all of the participants lived independently and were able to attend the testing 
session on the UNLV campus, suggesting, perhaps, a higher level of overall ability.
In addition to finding disparities between the two studies with regard to both testing 
locations and residence types, differences can also been found in demographic variables. 
When analyzing both the French (2005) and current studies, differences in education, 
(%^ (7, 50) = 41.72,/» < .01) and ethnicity (% (^5, 50) = 11.32,/» < .05) emerged. With 
regard to education, participants in the current study had significantly higher levels of
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education; participants in the current study had completed, on average, a Bachelor’s 
degree, whereas participants in French’s 2005 study had completed, on average, only 
some college without receiving even an Associate’s or technical degree. Furthermore, 
only 8% of participants in the current study were ethnic minorities compared to 20% in 
the French (2005) study. Please refer to Table 5 for a comparison of demographic 
variables between French’s 2005 study and the current study.
Another possibility for the discrepancy in results between studies rests in the 
differences in sample sizes. French (2005) found a moderate correlation (r = 26, p  < .01) 
between family history and the FADS, whereas a much smaller relation was found in the 
current study (r = . 10,/> > .05). Although not significant, the relation between farnily 
history and the FADS in the current study is in a similar direction as that in the study by 
French (2005). It is possible that a larger sample size would allow for greater variability 
in both family history and the FADS, possibly yielding a stronger and more significant 
relation. This conjecture is further supported when examining effect sizes.
In the current study the sample size was sufficient enough to replicate some of the 
more robust effects from the French (2005) study. Specifically, in both studies, 
subjective memory was associated with and predictive of fear of developing Alzheimer’s 
disease. In addition, given the smaller sample size in the current study (N = 51) versus 
that of French (2005; N = 101), the robustness of the effect o f one’s appraisal on one’s 
own memory in the prediction of fear of developing AD, is further exemplified. A 
smaller sample size than that in French’s 2005 study did, however, seem to contribute to 
the lack of replication of results that were less robust. Specifically, power analyses
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indicated that many more participants would be needed to replicate the prior findings of a 
significant relation between family history of AD and one’s fear of developing AD.
Taken together, differences in demographic variables as well as a possibly 
insufficient sample size may be contributing to the lack of replication of the relationship 
between family history and fear of developing AD. Future investigation would benefit 
from sampling a larger and more diverse, both ethnically and educationally, population. 
Specifically, a sample of twice to three times that in the current study as well as a 
population with more lower end variability with regard to education as well as a greater 
representation o f minorities might increase the likelihood of replicating the less robust 
findings o f French (2005).
Fear o f  Developing AD and Knowledge o f  AD
Few studies have addressed the relationship between knowledge of AD and anxiety 
regarding development of the disease. Of these studies, one found no relationship 
between knowledge of AD and fear (Commissaris et al., 1994), another found that 
increased knowledge of AD decreased fear o f AD (Commissaris et al., 1995), and the last 
found that, as knowledge of AD increased so did fear of developing the disease (LaForce 
& McLean, 2005).
Based upon the previous studies and the Medical Students’ Disease construet, it was 
hypothesized that as knowledge of AD increased so would fear of developing the disease. 
Unfortunately only a small, non-significant correlation {r = -AO,p >.05) was found 
between knowledge of AD and fear of developing AD. In addition, the subsequent 
regression analysis o f factors contributing to fear of developing AD, knowledge, as an 
individual predictor, did not contribute significantly to the prediction o f fear of
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developing AD {fs = -.056, -.045; p  > .05). O f note, however, is the fact that the 
measurement of AD was based on the KADS. And, although the parent measure of the 
KADS (i.e., ADKT) was a psychometrically sound instrument, the KADS is currently in 
its pilot form, and thus, may not have the same psychometric properties as the original 
questionnaire, thereby possibly affecting the results of the study.
It is difficult to interpret this finding. There are relatively few studies comparing 
knowledge of AD and fear of developing AD and of those extant studies, none is in 
agreement. Results from this study, however, are consistent with Commissaris and 
colleagues’ (1994) results. Future research using comparable methodology will aid in 
determining whether or not “a lot of knowledge [is] a bad thing.. .” (Chapman & Bilton, 
2004, p. 369).
Fear o f Developing AD and Objective Memory
Whereas it was hypothesized that subjective memory, family history o f AD, and 
knowledge of AD would be both be positively correlated with and significant predictors 
of fear of developing AD, objective memory was thought to not be associated with or 
predictive of this fear, which is precisely what was found in the current study. This result 
suggests that, regardless of an individual’s actual memory performance on standardized 
tests of memory, he/she will not be afraid of developing AD. Individuals with impaired 
memory will be no more afraid of developing AD than individuals with a good/”normal” 
memory. Only one other study has directly examined this relationship (French, 2005). 
The current finding is important because it replicates the results found in this previous 
study.
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Previous research has shown that individuals with actual memory impairments do not 
believe, or at least they do not admit, that they have a problem (Bouchard & Rossor, 
1999). Additionally, both the current study and previous studies have revealed that 
individuals are afraid o f developing the disease if they believe their memory is poor. 
Therefore, the current study lends support to the notion that memory-impaired individuals 
are not afraid of developing AD because they do not believe they have a memory 
problem.
Relationship between Knowledge of AD and Levels of Anxiety 
Only two studies thus far have addressed the relationship between knowledge of AD 
and anxiety (Graham et al., 1997a; Proctor et al., 2002). These studies found that as 
knowledge of dementia increased, so did anxiety. Based upon the previous studies, the 
Medical Student Disease concept, and the hypothesis that knowledge of AD would be 
associated with fear of developing AD (as discussed in the introduction), it was also 
conjectured that knowledge of AD would be associated with anxiety. This hypothesis 
was not substantiated.
One reason for the disparity in results may be a reflection of the population being 
examined. Both Graham et al. (1997a) and Proctor et al. (2002) tested the relationship 
between knowledge of AD and anxiety using caregivers of dementia patients. The current 
study utilizes older adults from the community. In fact, only 10% of the participants 
were caregivers to patients with AD at the time of testing. Being a caregiver can 
dramatically increase not only knowledge of AD, but also anxiety levels (Mahoney, 
Regan, Katona, & Livingston, 2005; Schulz, O ’Brien, & Bookwala, 1995). Therefore, if
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the current study utilized caregivers as the previous studies did, the hypothesis may have 
heen substantiated.
Relationship between Subjective and Objective Memory 
In the current study it was hypothesized that there would he no relationship between 
subjective and objective memory. This hypothesis was substantiated suggesting that an 
individual’s perception of his/her memory does not accurately reflect the individual’s 
actual memory. Previous research investigating the relationship between subjective and 
objective memory has heen mixed. Some research has found a positive relationship 
between the two variables (Gagnon et al., 1994; Jonker et al., 1995; Jonker et al., 1996; 
Johansson et al., 1997; McPherson et al., 1995; Wang et al., 2000; Zelinski et al., 1980). 
Most research, however, has found either a weak/modest relationship (Bolla et al., 1991 ; 
Hertzog et al., 2000; Schmidt et al., 2001; Zelinski et al., 2001) or no relationship 
(French, 2005; Kahn et al., 1975; Riedel-Heller et al., 1999; Schofield et al., 1997). The 
current study provides additional information in support of the belief that there is no 
significant relationship between subjective and objective memory. And, because many of 
the methodological problems (i.e. utilizing single-item questionnaires or measures 
without good psychometric properties to address subjective memory) plaguing previous 
studies were corrected in the current study, it gives even further credibility to this notion.
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The Relationship between Fear of Developing Alzheimer’s Disease and 
Subjective Memory Complaints after Controlling for Negative Mood 
To ensure that the relationship between subjective memory and fear of developing 
AD was not due to negative mood in the current study, the effects of negative mood were 
statistically removed from the correlation between the subjective memory measure and 
the FADS. The correlation between subjective memory and fear of developing AD 
remained significant even after removing the effects o f negative mood suggesting that 
negative mood does not impact an individual’s perception of his/her memory.
Individuals who believe their memory is poor are afraid of developing AD regardless of 
whether or not their mood is negative.
Limitations and Future Research 
The current study was able to improve upon many of the previous studies by 
addressing several of their limitations. For example, in the current study we (1) used a 
psychometrically sound instrument for measuring fear of developing AD, (2) used a 49 
item questionnaire to assess knowledge of AD rather than asking just a few questions, (3) 
excluded individuals using cognitive enhancing medication, and (4) utilized community- 
dwelling individuals ages 65 and older who are at particular risk for developing AD. Yet, 
even though great effort was made in addressing limitations from previous studies, not all 
limitations could be foreseen.
The generalizability of the findings of the current study to the broader population may 
be somewhat limited due to the nature of the participants. First, in the current study, the 
researchers were able to obtain a fairly representative sample o f community-dwelling
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Caucasian individuals. However, older adults from ethnic minority groups were 
underrepresented. Secondly, individuals were recruited mainly from the general 
community; only a few participants were recruited from senior institutions. Thus, caution 
should be taken in generalizing results o f this study to older adults from underrepresented 
ethnic groups and living facilities other than those in the general community.
Secondly, participants included in the study were pre-screened for gross memory 
impairment and neurological disorders. Therefore, results of the study can only be 
generalized to individuals with no known neurological impairments and those without 
obvious dementia.
Other major limitations of the current study pertain to family history o f AD. Only 
24% of individuals reported a family history of AD. This number is reduced to 12% 
when looking specifically at first-degree relatives with the disease. As discussed 
previously, having a larger sample size in general and a larger sample size of individuals 
with a family history of AD more specifically, may yield stronger results than the ones 
found in the current study. Additionally, a larger sample o f this nature would also allow 
researchers to make valid comparisons between individuals with and without a family 
history of AD.
Measuring family history of AD in older adults is difficult. The current study used 
self-report data from participants. This is problematic in that individuals must rely upon 
retrospective information of family members that may or may not be accurate. This is in 
part due to the fact that Alzheimer’s disease as a labeled medical condition did not gain 
wide-spread use until approximately 25-30 years ago when the National Institute of 
Health / National Institute on Aging was established. And, it was not even until several
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years after the inception of the NIA that researchers began receiving funding for 
exploration of AD and related dementias (Kalamazoo Center for Medical Studies, n.d.). 
Therefore, many of the participants may not have factual information about their 
relatives’ diagnoses as many of the inflicted relatives lived prior to the AD social 
movement. Having information from both the participant and an additional, reliable 
informant could confirm that a family history of AD actually existed. Another option 
would be to use medical records o f diagnosed family members to confirm a diagnosis of 
AD.
Another limitation lies in the measure being used to address knowledge of AD. The 
Knowledge about Alzheimer’s Disease Scale (KADS; Carpenter et al., 2006) employed 
in the dissertation is in its pilot form. The psychometric properties of this questionnaire 
have yet to he determined. Furthermore, the True/False response choices do not allow for 
significant variation in responses. And, most individuals, although reporting that they do 
not know much about AD, actually performed fairly well on the test causing a ceiling 
effect. Future research using the KADS in its psychometrically sound form will aid in 
determining the accuracy of the current study’s results.
Finally, subjective memory accounts for only 9.3% of the variance in fear of 
developing AD. Future research might explore what other variables account for the 
remaining variance. Some of these potential variables worth exploring include additional 
risk factors such as head injury and vascular health, financial constraints, relationship 
with potential caregivers, and spiritual beliefs.
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Conclusion
In the current study we found that: (1) in-line with existing studies, subjective 
memory was positively associated with fear of developing AD, (2) family history, 
knowledge of AD, and objective memory were not significantly correlated with fear of 
developing AD, (3) subjective memory was the only significant predictor of fear of 
developing AD; neither family history, knowledge of AD, nor objective memory 
predicted fear o f developing the disease, (4) knowledge of AD was not associated with 
anxiety, (5) there was no significant relationship between subjective and objective 
memory, and (6) the relationship between subjective memory and fear of developing AD 
was still significant after controlling for participants’ negative mood.
From a research perspective, the results of the current study are novel and important 
for several reasons. To date, the few published studies examining peoples’ fear of 
developing AD have focused on correlating fear with only two main variables: anxiety or 
subjective memory. The current study not only replicated these published studies in 
finding positive associations between fear of developing AD and anxiety or subjective 
memory but also extended these previous results by including additional relevant 
variables such as subjective and objective memory function, family history, and 
knowledge of AD. Even though these additional variables failed to exhibit significant 
correlations with fear o f developing AD, we have a better understanding o f how they 
relate to such fear.
From a clinical standpoint, these findings will aid clinicians in determining what 
aspects are possibly contributing to their clients’ fears of developing AD. In addition to 
therapy, psychoeducation about the relationship between fear o f developing AD and
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subjective memory complaints, family history, knowledge of AD, and objective memory 
may prove beneficial to clients in that it may help assuage their fears o f developing AD.
In conclusion, Alzheimer’s disease is becoming increasingly prevalent. Yet, older 
adults’ fear of developing AD has received little attention in the literature. Part of this 
may be due to the fact that, until recently, there were no psychometrically sound 
instruments to measure this tear. The development of the Fear of Alzheimer’s Disease 
Scale (FADS; French, 2005) provides researchers the opportunity to explore older adults’ 
fear of developing AD and along with this instrument, the variables possibly affecting 
fear of developing this degenerative disease.
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Table 1
Maximum Scores, Means and Standard Deviations o f  Measures and their Subscales 
(A-JO)
Measure Max Mean SD
Fear o f Alzheimer’s Disease Scale (FADS) 120 25.44 20.91
General Fear 68 18.02 14.30
Physical Symptoms 32 1.42 4.20
Catastrophic Attitude 20 6.00 4.69
Memory Functioning Questionnaire (MFQ) 448 284.14 48.62
General Frequency of Forgetting 224 164.00 2638
Seriousness of Forgetting 126 8236 23.15
Retrospective Functioning 35 16.06 4.92
Mnemonic Usage 56 21.72 10.52
Knowledge about Alzheimer's Disease Scale (KADS) 49 37.54 3.80
Perceived Knowledge of AD 10 5.38 1.75
Composite Score of Objective Memory 237 120.92 2836
Logical Memory I Recall Total Score 75 38.82 10.34
Logical Memory I Scaled Score 11.64 3.04
Logical Memory II Recall Total Score 50 23T8 9.01
Logical Memory II Scaled Score 12.04 3.16
CVLT-II Recall Total Score 80 47.80 10.14
CVLT-II Recall T-Score 57.64 10.13
CVLT-II Short Delay Recall 16 9.76 3.11
CVLT-II Long Delay Recall 16 10.80 3.31
Composite Score of Cognitive Measures 442 243.48 41.62
Digit Symbol Total Score 133 63.20 13.52
Digit Symbol Scale Score 12.62 2.76
Incidental Learning Pairing 18 9.94 4.27
Incidental Learning Free Recall 9 6.72 1.40
Digit Span Total Score 30 18.70 3.75
Digit Span Scaled Score 12.88 2.96
Boston Naming Test Total Score 15 14.72 0.57
Geriatric Depression Scale (GDS) 30 4.60 4.73
State-Trait Anxiety Inventory -  Form Y (STAI) 160 60.62 17.23
State Anxiety Subscale 80 2934 10.20
Trait Anxiety Subscale 80 31.28 8.78
Note. The Composite Score of Cognitive Measures includes both the measures listed and 
the measures contained in the Composite Score o f Objective Memory.
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Table 2
Percentage o f  responses fo r  the Fear o f  Alzheimer’s Disease Scale (N  = 50)
Item Never Rarely Some often Always
________________________________________________________________________  times________________2__
I am afraid of getting Alzheimer’s disease. 10 34 40 14 2
24 42 24 8 2When I forget something, I am apt to think that I am developing Alzheimer’s disease.
My heart races or palpitates when I think about 
getting Alzheimer’s disease.
I cannot sleep because I’m worrying about 
developing Alzheimer’s disease.
I would rather die than develop Alzheimer’s 
disease.
82 14
92
52 16 16
28 30 26 101 am afraid of developing Alzheimer’s disease because o f the burden 1 would be for my family.
When 1 think about the possibility of developing
Alzheimer’s disease, 1 become nervous or 60 26 10
anxious.
The more 1 learn about Alzheimer’s disease, the 
more fearful 1 become of getting it. 42 28 22
When 1 misplace things, 1 sometimes think that 1 
may have Alzheimer’s disease.
1 feel hot and even sweat when 1 think about 
developing Alzheimer’s disease.
Developing Alzheimer’s disease would be the 
worst thing to happen to me.
Thinking about Alzheimer’s disease makes me 
feel fatigued.
36 34 24
86 10 2
44 20 22
1 fear not recognizing family members. 48 30 8 12
58 20 16 81 think that 1 will probably get Alzheimer’s disease and it frightens me.
Even though my memory is good, 1 am still 
afraid of developing Alzheimer’s disease.
My hands become clammy when 1 think about 
getting Alzheimer’s disease.
26 42 22 10
9 0
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Item Never Rarely Some­times Often Always
I often have difficulty concentrating because 
I’m worrying about developing Alzheimer’s 
disease.
Developing Alzheimer’s disease frightens me 
because 1 would eventually lose all o f my 
independence.
Now that Alzheimer’s disease is becoming more 
public with the diagnosis of popular T.V., 
movie, and political figures (e.g., Charlton 
Heston, Ronald Reagan), 1 am becoming more 
afraid that 1 may develop it.
1 feel shaky when 1 think about getting 
Alzheimer’s disease.
My appetite decreases when 1 think about 
developing Alzheimer’s disease.
1 would rather have a painful physical illness 
(e.g., cancer, AIDS) than develop Alzheimer’s 
disease.
When 1 hear about others with Alzheimer’s 
disease, 1 become fearful that 1 will get it as 
well.
I’m afraid of losing my memories.
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36
48
86
98
56
40
28
26
36
22
34
22
18
14
12
20
34
12
12
The older 1 get, the more fearful 1 become that 1 
may develop Alzheimer’s disease.
1 believe that Alzheimer’s disease is one of the 
worst diseases a person could develop.
1 worry about developing Alzheimer’s disease 
more than 1 worry about developing other 
diseases.
I’m afraid o f getting Alzheimer’s disease 
because 1 would have to rely on someone else to 
take care of me.
The worse my memory becomes, the more 1 fear 
that 1 may have Alzheimer’s disease.
1 sometimes think that 1 am developing 
Alzheimer’s disease.
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58
28
36
58
34
22
18
30
38
26
24
28
16
16
10
10
14 12
16 10
10
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Table 3
Correlations among Measures
FADS MFQ KADS GDS STAI ObjectiveMemory
Cognitive
Measures
Family
History .10 .17 .24 -.18 .22 -.01 .01
FADS 3 3 * -.10 .42** .44** -.13 - 3 2
MFQ -.17 .16 .41** - 3 6 - 3 6
KADS -3 9 * - 3 8 * 3 3 * 3 9 *
GDS .71*** -.07 -.12
STAI -.19 - 3 2
Objective
Memory
gg***
Note. FADS = Fear o f Alzheimer’s Disease Scale; MFQ = Memory Functioning Questionnaire; 
GDS = Geriatric Depression Scale; STAI = State-Trait Anxiety Inventory; Objective Memory is 
the composite score o f the memory measures; Cognitive Measures is the composite score o f the 
Objective Memory tests plus the additional cognitive measures.
* p < . 0 5 .  **p< .01. * * V <  .001.
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Table 4
Summary o f  Hierarchical Regression Analysis fo r  Variables Predicting Fear o f  
Developing Alzheimer’s Disease (N  = 50)
Variable B SE E B Adjusted Change
Step 1 .09 .11
MFQ .14 .06 .33*
Step 2 .08 .00
MFQ .14 .06 .33*
Family History .96 2.88 .05
Step 3 .06 .00
MFQ .14 .06 .31*
Family History 1.28 3.02 .06
KADS -.31 .81 -.06
Step 4 .06 .02
MFQ .13 .06 .31*
Family History 1.24 3.06 .06
KADS -.25 .85 -.05
Objective Memory -.19 .76 -.04
Note. MFQ = Memory Functioning Questionnaire; Family History is the number of 
relatives with Alzheimer’s disease; KADS = Knowledge About Alzheimer’s Disease; 
Objective Memory is the composite score of the memory measures.
*p < .05.
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Table 5
Demographic information fo r  participants in the French (2005) study (N  = 101) and the 
current study
Demographic Variable French (2005) (% of participants)
Current Study 
(% of participants)
Age M=73.45; SD=6.86 M=72.24; SD=5.37
Gender
Male 35 48
Female 65 52
Marital Status
Single 4 10
Married 44 52
Divorced 22 22
Widowed 30 16
Ethnicity
African American 13 2
Asian 1 , 4
Caucasian 80 92
Latino/Hispanic 5 0
Native American 0 2
Pacific Islander/Filipino 0 0
Other 1 0
Religious Affiliation
Buddhist 0 2
Catholic 22 10
Jewish 11 18
Muslim 0 0
Protestant 39 26
Latter Day Saints 2 2
No Affiliation 23 40
Other 3 2
Education Level
Some high school or less 11 4
Graduated Fligh School (or GED) 42 14
Technical or Associate’s degree 8 4
Some College 1 26
Bachelor’s degree 22 20
Some graduate school 0 2
Master’s degree 12 14
PhD, JD, or MD Degree 4 16
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APPENDIX II 
MENTAL STATUS QUESTIONNAIRE (MSQ)
QUESTION RESPONSE RIGHT
(1)
WRONG
(0)
1. What is the name of this 
place?
2. Where is it located 
(address)?
3. What is today’s date?
4. What is the month now?
5. What is the year?
6. Plow old are you?
7. When were you bom 
(month)?
8. When were you bom 
(year)?
9. Who is the president of 
the U.S.?
10. Who was the president 
before him?
TOTAL SCORE
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APPENDIX III 
PERSONAL BACKGROUND INFORMATION
Name:
Address:
C ity:________________  State:_____________  Zip Code:
Home Phone: Work Phone:
Can we leave a message at these numbers? □  Yes □  No
A ge:__________  Date o f B irth:____________
Gender: □  Male □  Female
Marital Status: □  Single □  Married □  Divorced OWidowed 
Ethnicity (Please check only one):
□  African American □  Asian □  Native American
□  Latino/Hispanic □  Caucasian □  Pacific Islander/Filipino
□  O ther:__________________________
Were you bom in the United States? □  No □  Yes
If NO, how old were you when you moved to the U. S .?_______
Do you speak English fluently? □  No □  Yes 
Religious Affiliation (Please check only one):
□  Buddhist □  Catholic □  Jewish □  Muslim
□  Protestant □  Latter Day Saints O O ther:_________________
What was your highest level of education?
□  Some high school or less
□  Graduated high school (or GED)
□  Some technical or associate coursework
□  Technical or associate’s degree
□  Some college
□  Bachelor’s degree
□  Some graduate school
□  Master’s degree
□  Doctoral (Ph.D., other doctoral) degree
□  Professional degree (e.g., M.D., J.D.)
7 1
What is/was your primary occupation?__________________________
Would you like to participate in future research if available? □  Yes □  No 
If  YES, can we contact you by phone? □  Yes □  No 
If  YES, can we contact you by mail? □  Yes □  No
 _________________________ MEDICAL HISTORY____________
Do you have any current medical problems? □  Yes □  No
If YES, please list what medical problems you currently have:
1. Medical Diagnosis/Problem:___________________________
2. Medical Diagnosis/Problem:___________________________
3. Medical Diagnosis/Problem:___________________________
Have you ever had open-heart surgery? □  Yes □  No
Have you ever been diagnosed with or had any of the following:
□  Parkinson’s Disease □  Huntington’s Disease
□  Alzheimer’s Disease □  Pick’s Disease
□  Creutzfeldt-Jakob Disease □  Vascular Dementia
□  Stroke □  Hydrocephalus
□  Brain damage □  Delirium
□  Endocrine Disorder (please list):____________________
□  Major organ system impairment (examples: heart, lung, liver,
kidney). Please lis t:___________________________________
Are you taking any of the following medications:
□  Aricept □  Exelon □  Reminyl
□Razadyne □  Cognex □  Namenda
Do you have any problems walking? □  Yes □  No
PSYCHIATRIC HISTORY ~
Have you ever been diagnosed with or had any of the following:
□  Major Depression □  Schizophrenia
□  Post-Traumatic Stress Disorder (PTSD)
□  Anxiety Disorder (please list type(s)):_____________________
□  Alcohol or substance abuse or dependence 
Other:
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Do you drink alcohol? □  Yes □  No 
If YES, please complete the following:
I . How frequently do you drink?_____
2. When you drink, what do you usually drink?_
Do you use any recreational drugs? □  Yes □  No 
If YES, please complete the following:
1. How frequently do you use recreational drugs?_
3. What recreational drugs do you use?
FAMILY HISTORY
Have any o f your biological family members ever been diagnosed with Alzheimer’s 
Disease? □  Yes DNo
□  First degree relative (Mother, Father, Sibling, Child)
Has more than one first degree relative been diagnosed with Alzheimer’s
Disease? □  Yes DNo
If YES, how many of your first degree relatives have been 
diagnosed?___________
How emotionally close are you to your first degree relative #1?
Not at all Close Somewhat Close Extremely Close
1 2 3 4 5
How emotionally close are you to your first degree relative #21
Not at all Close Somewhat Close Extremely Close
1 2 3 4 5
How emotionally close are you to your first degree relative #3?
Not at all Close Somewhat Close Extremely Close
1 2 3 4 5
How emotionally close are you to your first degree relative #4?
Not at all Close Somewhat Close Extremely Close
1 2 3 4 5
□  Second degree relative (Grandfather, Grandmother, Aunt, Uncle)
Has more than one second degree relative been diagnosed with
Alzheimer’s Disease? □  Yes DNo
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If  YES, how many of your second degree relatives have been
diagnosed?__________
How emotionally close are you to your second degree relative #1?
Not at all Close Somewhat Close Extremely Close
1 2 3 4 5
How emotionally close are you to your second degree relative #2?
Not at all Close Somewhat Close Extremely Close
1 2 3 4 5
How emotionally close are you to your second degree relative #3?
Not at all Close Somewhat Close Extremely Close
1 2 3 4 5
How emotionally close are you to your second degree relative #4?
Not at all Close Somewhat Close Extremely Close
1 2 3 4 5
QUESTIONS PERTAINING TO ALZHEIMER’S DISEASE 
Have you heard of Alzheimer’s disease? □  No □  Yes
Are you currently the main family caregiver for someone with Alzheimer’s disease or a 
related disorder? □  No □  Yes
Have you ever been the main family caregiver for someone with Alzheimer’s disease or a 
related disorder? □  No □  Yes
Have you ever attended an Alzheimer’s disease or related disorder support group?
□  No □  Yes
Have you ever attended a class or educational program about Alzheimer’s disease or a 
related disorder? □  No □  Yes
Does your paid job involve working with people who have Alzheimer’s disease or a 
related disorder? □  No □  Yes
Do you volunteer with people who have Alzheimer’s disease or a related disorder?
□  No □  Yes
7 4
From which of the following places have you obtained information about Alzheimer’s 
disease and related disorders? (check all that apply)
□  family
□  friends and acquaintances
□  physicians or other health care professionals
□  Alzheimer’s Association
□  television or radio
□  books, newspapers, or magazines
□  religious leaders
□  MEDLINE, PubMed, or similar professional databases
□  other Internet or World Wide Web sites
□  academic journals
□  research conferences
□  other sources (please list):__________________________________________
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APPENDIX IV
FEAR OF ALZHEIMER’S DISEASE SCALE (FADS)
Instructions: Please indicate your level of agreement with each 
statement by checking the appropriate box.
(Check one
Rarely Some­times Often Always
1 .1 am afraid of getting Alzheimer’s 
disease. □ □ □ □ □
2. When I forget something, I am apt 
to think that I am developing 
Alzheimer’s disease.
P □ u ' E i
3. My heart races or palpitates when 
I think about getting Alzheimer’s 
disease.
□ □ □ □ □
4 . 1 cannot sleep because I ’m 
worrying about developing 
Alzheimer’s disease.
■ O ' / 7 □ □ : □
5 .1 would rather die than develop 
Alzheimer’s disease. □ □ □ □ □
6 .1 am afraid of developing 
Alzheimer’s disease because of the 
burden I would be for my family.
□ □ □
7. When I think about the possibility 
of developing Alzheimer’s disease, I 
become nervous or anxious.
□ □ □ □ □
8. The more I learn about 
Alzheimer’s disease, the more 
fearful I become of getting it.
□ □
9. When I misplace things, I 
sometimes think that I may have 
Alzheimer’s disease.
□ □ □ □ o
10.1 feel hot and even sweat when I 
think about developing Alzheimer’s 
disease.
□ : q
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Check one
Never . Rarely Some­times Ofteii Always
11. Developing Alzheimer’s disease 
would be the worst thing to happen 
to me.
□ □ □ □ □
12. Thinking about Alzheimer’s 
disease makes me feel fatigued. □
□
13.1 fear not recognizing family 
members. □
□ □ □ □
14.1 think that 1 will probably get 
Alzheimer’s disease and it frightens 
me.
□ □
15. Even though my memory is 
good, I am still afraid o f developing 
Alzheimer’s disease.
□ □ □ □ □
16. My hands become clammy when 
I think about getting Alzheimer’s 
disease.
□  : : □ □ □
17.1 often have difficulty 
concentrating because I ’m worrying 
about developing Alzheimer’s 
disease.
□ □ □ □ □
18. Developing Alzheimer’s disease 
frightens me because I would 
eventually lose all of my 
independence.
□
19. Now that Alzheimer’s disease is 
becoming more public with the 
diagnosis of popular T.V., movie, 
and political figures (e.g., Charlton 
Heston, Ronald Reagan), I am 
becoming more afraid that I may 
develop it.
□ □ □ □ □
2 0 .1 feel shaky when I think about 
getting Alzheimer’s disease. □ □ □
21. My appetite decreases when I 
think about developing Alzheimer’s 
disease.
□ □ □ □ □
2 2 .1 would rather have a painful 
physical illness (e.g., cancer, AIDS) 
than develop Alzheimer’s disease.
□
23. When I hear about others with 
Alzheimer’s disease, I become 
fearful that I will get it as well.
□ □ □ □ □
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Check one
Never: Rarely Some­times Often Always
24. I ’m afraid of losing my 
memories. □ □ □ □ □
25. The older I get, the more fearful I 
become that I may develop 
Alzheimer’s disease.
□
2 6 .1 believe that Alzheimer’s 
disease is one of the worst diseases a 
person could develop.
□ □ □ □ □
27. I worry about developing 
Alzheimer’s disease more than I 
worry about developing other 
diseases.
□ □
28. I ’m afraid of getting Alzheimer’s 
disease because I would have to rely 
on someone else to take care of me.
□ □ □ □ □
29. The worse my memory becomes, 
the more I fear that I may have 
Alzheimer’s disease.
□
3 0 .1 sometimes think that I am 
developing Alzheimer’s disease. □ □ o □ □
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APPENDIX V
MEMORY FUNCTIONING QUESTIONNAIRE (MFQ)
Instructions: This is a questionnaire about how you remember information. There are no 
right or wrong answers. Circle a number between 1 and 7 that best reflects your judgment 
about your memory. Think carefully about your responses, and try to be as realistic as 
possible when you make them. Please answer all questions.___________________________
General Frequency of Forgetting
How would you rate your memory in terms of the kinds of problems that you have? 
major problems some minor problems no problems
1 2 3 4 5 6 7
How often do these present a problem for you?
always sometimes never
a. names 2 3 5 AH''
b. faces 1 2 3 4 5 6 7
c. appointments 'ÏT /''' y:4:)' 5':::; 6 ;
d. where you put things (e.g., keys) 1 2 3 4 5 6 7
e. performing household chores - : 3 ' 4 ' 6 7
f. directions to places 1 2 3 4 5 6 7
g. phone numbers you’ ve just checked y 3;v 6 7
h. phone numbers you use frequently 1 2 3 4 5 6 7
i. things people tell you ,\/Tx j/A ': ^ 6
j. keeping up correspondence 1 2 3 4 5 6 7
k. personal dates (e.g., birthdays) ; 2 U g 'y 6
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How often do these present a problem for you?
always sometimes never
1. words : 0 : i 2 A 4 ' ' ^ 5
m. going to the store and forgetting what 
you wanted to buy 1 2 3 4 5 6 7
n. taking a test '  "5-
0. beginning to do something and 
forgetting What you were doing 1 2 3 4 5 6 7
p. losing the thread o f thought in 
conversation 1 2 y 6
q. losing the thread of thought in public 
speaking 1 2 3 4 5 6 7
r. knowing whether you’ve already told 
someone something 2 3 5 A # '- 7
As you are reading a novel, how often do you have trouble remembering what you have 
read ...
always sometimes never
a. in the opening chapters, once you have 
finished the book ' A- y ;ÿ - N ' t A ^ y ;T /êy 7
b. three or four chapters before the one you 
are currently reading 1 2 3 4 5 6 7
c. the chapter before the one you are 
currently reading ' d' A2y ; :y'3'A, 'A 4 :' \.5yC 7
d. the paragraph just before the one you 
are currently reading 1 2 3 4 5 6 7
e. the sentence before the one you are 
currently reading 2 ' 3 : 4 5: / 6 7
When you are reading a newspaper or magazine article, how often do you have trouble 
remembering what you have read...
a. in the opening paragraphs, once you 
have finished the article 1 y.3'7:; ;■ 6
b. three or four paragraphs before the one 
you are currently reading 1 2 3 4 5 6 7
c. the paragraph before the one you are 
currently reading 1 7^ '27^
-7 3  7" A 4:y.
d. three or four sentences before the one 
you are currently reading 1 2 3 4 ' 5 6 7
e. the sentence before the one you are 
currently reading 1 : 7v 37.: '7:4f
5:7 . # y ;'.7./
sometimes never
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How well you remember things that occurred...
very bad fair very good
a. last month is 1 2 3 4 5
b. between 6 months and 1 year ago is 1 2 3 4 5 6 7
c. between 1 and 5 years ago is 1 2 3 : 't  7
d. between 6 and 10 years ago is 1 2 3 4 5 6 7
Seriousness of Forgetting
When you actually forget in these situations, how serious of a problem do you consider 
memory failure to be? ... very not
serious somewhat serious serious
a. names 2 7;5;7: 6 7: :
b. faces 1 2 3 4 5 6 7
c. appointments ; V f: 2 7 ,5 ::/ y 6 /7 ;\/;7/'
d. where you put things (e.g., keys) 1 2 3 4 5 6 7
e. performing household chores 2 : ;3: : '::'4y' 5 /y & y 7
f. directions to places 1 2 3 4 5 6 7
g. phone numbers you’ve just checked 3 r 4 /VS'A 6 7
h. phone numbers used frequently 1 2 3 4 5 6 7
i. things people tell you ',;1;A ;:-3A: 4 y 5 6
j. keeping up correspondence 1 2 3 4 5 6 7
k. personal dates (e.g., birthdays) y H ':- 7 :3 - ' / :3.;-‘ y  5:': 6 y 7
1. words 1 2 3 4 5 6 7
m. going to the store and fbrgetting what 
you wanted to buy 2 :y 3 '$ ;r5 //- A'ô:.; 7 y  7 //
n. taking a test 1 2 3 4 5 6 7
0. beginning to do something and 
forgetting what you were doing 1 2 3 4 '7:6'.:: / / j y :
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When you actually forget in these situations, how serious of a problem do you consider 
memory failure to be? ... very not
serious somewhat serious serious
p. losing the thread o f thought in 
conversation 1 2 3 4 5 6 7
q. losing the thread o f thought in public 
speaking 1 2 3 4 5 6 7
r. knowing whether you’ve already told 
someone something 1 .. 2 . 3 - 4 % 7' 5;.:: 6 .77/7/}/
Retrospective Functioning
How is your memory compared to the way it w as...
much
worse same
much
better
a. 1 year ago? 1 2 7y37.7 7747} 7 6 % }7:6}7; /7:7/
b. 5 years ago? 1 2 3 4 5 6 7
c. 10 years ago? 1 7 7/: 3^ 77477 '7 # - ' 6 777'7/'
d. 20 years ago? 1 2 3 4 5 6 7
e. when you were 18? 1 - 727.1- 3 : 4 7 / 77.3 7:76: }7 '7:7^ 77
Mnemonic Usage
How often do you use these techniques to remind yourself about things...
always sometimes never
a. keep an appointment book 7:-..f;7.' 2 77 37; 4 7 5 „ 6 }..7',7
b. write yourself reminder notes 1 2 3 4 5 6 7
c. make lists of things to do 2 3 7/4:7}} 7:75:7/.}:-U6y' 77-9'7X
d. make grocery lists 1 2 3 4 5 6 7
e. plan your daily schedule in advance -./.:f 7: .7 .-'2:yy./773 7/4:7 :'774% 6 ../':'7:
f. mental repetition 1 2 3 4 5 6 7
g. associations with other things 7/7l.':..7. 2 %377 4 5 6 : ; i f \
h. keep things you need to do in a
prominent place where you will notice 
them
1 2 3 4 5 6 1
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APPENDIX VI
KNOWLEDGE ABOUT ALZHEIMER’S DISEASE
Below are some statements about Alzheimer’s disease. Please read each statement 
carefully and check whether you think the statement is True or False. If  you aren’t sure 
of the right answer, make your best guess. It’s important to check an answer for every 
statement even if you’re not completely sure of the answer.
Check One
I . An evaluation of a person for Alzheimer’s disease typically 
includes information from a physical exam, memory tests, 
brain scans, and a history of the symptoms.
□  T rue □  False
2. People with Alzheimer’s disease are particularly prone to 
depression. □  True O  False
3. In general, as people with Alzheimer’s disease get worse, 
they are more likely to wander and get lost. □  True □  False
4. Medications can permanently stop Alzheimer’s disease 
from getting worse. □  True □  False
5. More than 50% of people over the age of 85 have 
Alzheimer’s disease. □  True □  False
6. It has been scientifically proven that mental exercise can 
prevent a person from getting Alzheimer’s disease. □  True □  False
7. After symptoms of Alzheimer’s disease appear, the average 
life expectancy is 6 to 12 years. □  T rue □  False
8. When a person with Alzheimer’s disease becomes agitated, 
a medical examination might reveal other health problems 
that caused the agitation.
□  True □  False
9. People with Alzheimer’s disease do best with simple 
instructions giving one step at a time. □  T rue □  False
10. When people with Alzheimer’s disease begin to have
difficulty taking care of themselves, caregivers should take 
over right away.
□  True □  False
11. If a person with Alzheimer’s disease becomes alert and 
agitated at night, a good strategy is to try to make sure that 
the person gets plenty of physical activity during the day.
□  True □  False
12. in rare cases, people have recovered from Alzheimer’s 
disease. □  True □  False
13. Having a parent or sibling with Alzheimer’s disease 
increases the chance o f developing it. □  True □  False
14. People whose Alzheimer’s disease is not yet severe can 
benefit from psychotherapy for depression and anxiety. □  True □  False
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Check One
15. Some people with Alzheimer’s disease cannot recognize 
their children when they see them. □  True □  False
16. Drivers in the early stages of Alzheimer’s disease have 
more auto accidents than other older drivers. □  True □  False
17. A person suspected o f having Alzheimer’s disease should 
be evaluated to rule out treatable disorders with similar 
symptoms.
□  True □  False
18. If trouble with memory and confused thinking appears 
suddenly, it is likely due to Alzheimer’s disease. □  True □  False
19. Currently, the best way to diagnose Alzheimer’s disease is 
with a blood test. /}Q»Triie7' □  False
20. Most people with Alzheimer’s disease live in nursing 
homes. □  True □  False
21. Poor nutrition can make the symptoms o f Alzheimer’s 
disease worse. □  True □  False
22. People in their 30s can have Alzheimer’s disease. □  True □  False
23. Taking vitamin E may reduce a person’s risk of developing 
Alzheimer’s disease. □  True □  False
24. A person with Alzheimer’s disease becomes increasingly 
likely to fall down as the disease gets worse. □  True □  False
25. If a person with Alzheimer’s disease follows the caregiver 
all over the house, it is helpful to encourage the person with 
Alzheimer’s disease to stay in one room.
□  T rue □  False
26. When people with Alzheimer’s disease repeat the same 
question or story several times, it is helpful to remind them 
that they are repeating themselves.
□  True □  False
27. Once people have Alzheimer’s disease, they are no longer 
capable o f making informed decisions about their own care. □  True □  False
28. Eventually, a person with Alzheimer’s disease will need 24- 
hour supervision. □  True □  False
29. Having high cholesterol may increase a person’s risk of 
developing Alzheimer’s disease. □  True □  False
30. Alzheimer’s disease can be caused by eating food that was 
cooked in aluminum pots. □  True □  False
31. The percentage of people over age 65 with Alzheimer’s 
disease exceeds 10%. □  True □  False
32. Tremor or shaking of the hands or arms is a common 
symptom of people with Alzheimer’s disease. □  True □  False
33 . Symptoms of severe depression can be mistaken for 
symptoms o f Alzheimer’s disease. □  True □  False
34. Alzheimer’s disease is one type of dementia. □  True □  False
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Check One
35. Trouble handling money or paying bills is a common early 
symptom of Alzheimer’s disease. □  True □  False
36. One symptom that can occur with Alzheimer’s disease is 
believing that other people are stealing one’s things. □  True
□  False
37. When a person has Alzheimer’s disease, using reminder 
notes is a crutch that can contribute to decline. □  True □  False
38. Prescription drugs that prevent Alzheimer’s disease are 
available. □  True □  False
39. Having high blood pressure may increase a person’s risk of 
developing Alzheimer’s disease. /O  .True/;, □  False
40. Genes can only partially account for the development of 
Alzheimer’s disease. □  True O False
41. It is safe for people with Alzheimer’s disease to drive, as 
long as they have a companion in the car at all times. □  True □  False
42. People with Alzheimer’s disease do best when exposed to 
new experiences and environments as often as possible. □  True □  False
43. People with Alzheimer’s disease have more problems 
remembering things on some days than on others. □  True □  F alse
44. Alzheimer’s disease is a normal part of aging, like gray hair 
or wrinkles. □  True □  False
45. Alzheimer’s disease progresses at the same speed for 
everyone. □  True □  False
46. Changes in personality may occur in people who have 
Alzheimer’s disease. □  True □  False
47. Alzheimer’s disease cannot be cured. □  True □  False
48. Frequent forgetfulness is the most common early sign of 
Alzheimer’s disease. □  True □  False
49. Most people with Alzheimer’s disease remember recent 
events better than things that happened in the past. □  True □  False
50. Circle any number between 1 and 10 to indicate how much knowledge you think you 
have about Alzheimer’s disease and related disorders.
1 7 8 10
I know nothing 
at all
I have some 
knowledge
I am very 
knowledgeable
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APPENDIX VII
GERIATRIC DEPRESSION SCALE (GDS)
Instructions: Please choose the best answer to describe how you’ve felt the last 2 weeks.
Check One
1. Are you basically satisfied with your life? v:;:-f3;Yes7 ;
2. Have you dropped many of your activities and 
interests? □  Yes □  No
3. Do you feel that your life is empty?  ^ 7::%7}Q;No-
4. Do you often get bored? □  Yes □  No
5. Are you hopeful about the future? 7 / //: □  Yes. □  No
6. Are you bothered by thoughts you can’t get out 
of your head? □  Yes □  No
7. Are you in good spirits most of the time? □  Yes □  No
8. Are you afraid that something bad is going to 
happen to you? □  Yes □  No
9. Do you feel happy most of the time? □  Yes
10. Do you often feel hopeless? □  Yes □  No
11. Do you often get restless and fidgety? □  Yes 7 7 : q N o . .}
12. Do you prefer to stay at home, rather than 
going out and doing new things? □  Yes □  No
13. Do you frequently worry about the future? □  Yes
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Check One
14. Do you feel you have more problems with 
memory than most? □  Yes 7 ; { q /N o
15. Do you think it is worthwhile to be alive now? □  Yes □  No
16. Do you often feel downhearted and blue? □  Yes □  No
17. Do you feel pretty worthless the way you are 
now? □  Yes □  No
18. Do you worry a lot about the past? □  Yes □  No
19. Do you find life very exciting? □  Yes □  No
20. Is it hard for you to get started on new projects? □  Yes No,. 77/7'-
21. Do you feel full of energy? □  Yes □  No
22. Do you feel that your situation is hopeless? □  Yes /; :% q /N o
23. Do you think that most people are better off 
than you are? □  Yes □  No
24. Do you frequently get upset over little things? □  Yes □  No
25. Do you frequently feel like crying? □  Yes □  No
26. Do you have trouble concentrating? □  Yes □  No
27. Do you enjoy getting up in the morning? □  Yes □  No
28. Do you prefer to avoid social gatherings? □  Yes □  No
29. Is it easy for you to make decisions? □  Yes □  No
30. Is your mind as clear as it used to be? □  Yes □  No
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